In file C:\xampp\htdocs\eclass\include\action.php on line 25 : Unable to execute statement:"Table '.\eclass\actions_daily' is marked as crashed and should be repaired", sqlstate:"145", errornum:"HY000", statement:"SELECT id, TIME_TO_SEC(TIMEDIFF(NOW(), last_update)) AS diff, module_id FROM actions_daily WHERE user_id = ? AND course_id = ? AND day = DATE(NOW()) ORDER BY last_update DESC LIMIT 1", elapsed:0.003

In file C:\xampp\htdocs\eclass\include\action.php on line 50 : Unable to execute statement:"Table '.\eclass\actions_daily' is marked as crashed and should be repaired", sqlstate:"145", errornum:"HY000", statement:"SELECT id FROM actions_daily WHERE user_id = ? AND module_id = ? AND course_id = ? AND day = '2024-07-23'", elapsed:0.002

In file C:\xampp\htdocs\eclass\include\action.php on line 71 : Unable to execute statement:"Table '.\eclass\actions_daily' is marked as crashed and should be repaired", sqlstate:"145", errornum:"HY000", statement:"INSERT INTO actions_daily SET user_id = ?, module_id = ?, course_id = ?, hits = 1, duration = 900, day = '2024-07-23' , last_update = NOW() ", elapsed:0.001

ID 140U_DROME Reviewed; 261 AA. AC P81928; Q9VFM8; DT 28-MAR-2003, integrated into UniProtKB/Swiss-Prot. DT 28-MAR-2003, sequence version 2. DT 03-APR-2007, entry version 39. DE RPII140-upstream gene protein. GN Name=140up; ORFNames=CG9852; OS Drosophila melanogaster (Fruit fly). OC Eukaryota; Metazoa; Arthropoda; Hexapoda; Insecta; Pterygota; OC Neoptera; Endopterygota; Diptera; Brachycera; Muscomorpha; OC Ephydroidea; Drosophilidae; Drosophila. OX NCBI_TaxID=7227; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION. RC TISSUE=Embryo; RX MEDLINE=91276237; PubMed=1905256; DOI=10.1016/0378-1119(91)90361-E; RA Sitzler S., Oldenburg I., Petersen G., Bautz E.K.F.; RT "Analysis of the promoter region of the housekeeping gene DmRP140 by RT sequence comparison of Drosophila melanogaster and Drosophila RT virilis."; RL Gene 100:155-162(1991). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Berkeley; RX MEDLINE=20196006; PubMed=10731132; DOI=10.1126/science.287.5461.2185; RA Adams M.D., Celniker S.E., Holt R.A., Evans C.A., Gocayne J.D., RA Amanatides P.G., Scherer S.E., Li P.W., Hoskins R.A., Galle R.F., RA George R.A., Lewis S.E., Richards S., Ashburner M., Henderson S.N., RA Sutton G.G., Wortman J.R., Yandell M.D., Zhang Q., Chen L.X., RA Brandon R.C., Rogers Y.-H.C., Blazej R.G., Champe M., Pfeiffer B.D., RA Wan K.H., Doyle C., Baxter E.G., Helt G., Nelson C.R., Miklos G.L.G., RA Abril J.F., Agbayani A., An H.-J., Andrews-Pfannkoch C., Baldwin D., RA Ballew R.M., Basu A., Baxendale J., Bayraktaroglu L., Beasley E.M., RA Beeson K.Y., Benos P.V., Berman B.P., Bhandari D., Bolshakov S., RA Borkova D., Botchan M.R., Bouck J., Brokstein P., Brottier P., RA Burtis K.C., Busam D.A., Butler H., Cadieu E., Center A., Chandra I., RA Cherry J.M., Cawley S., Dahlke C., Davenport L.B., Davies P., RA de Pablos B., Delcher A., Deng Z., Mays A.D., Dew I., Dietz S.M., RA Dodson K., Doup L.E., Downes M., Dugan-Rocha S., Dunkov B.C., Dunn P., RA Durbin K.J., Evangelista C.C., Ferraz C., Ferriera S., Fleischmann W., RA Fosler C., Gabrielian A.E., Garg N.S., Gelbart W.M., Glasser K., RA Glodek A., Gong F., Gorrell J.H., Gu Z., Guan P., Harris M., RA Harris N.L., Harvey D.A., Heiman T.J., Hernandez J.R., Houck J., RA Hostin D., Houston K.A., Howland T.J., Wei M.-H., Ibegwam C., RA Jalali M., Kalush F., Karpen G.H., Ke Z., Kennison J.A., Ketchum K.A., RA Kimmel B.E., Kodira C.D., Kraft C.L., Kravitz S., Kulp D., Lai Z., RA Lasko P., Lei Y., Levitsky A.A., Li J.H., Li Z., Liang Y., Lin X., RA Liu X., Mattei B., McIntosh T.C., McLeod M.P., McPherson D., RA Merkulov G., Milshina N.V., Mobarry C., Morris J., Moshrefi A., RA Mount S.M., Moy M., Murphy B., Murphy L., Muzny D.M., Nelson D.L., RA Nelson D.R., Nelson K.A., Nixon K., Nusskern D.R., Pacleb J.M., RA Palazzolo M., Pittman G.S., Pan S., Pollard J., Puri V., Reese M.G., RA Reinert K., Remington K., Saunders R.D.C., Scheeler F., Shen H., RA Shue B.C., Siden-Kiamos I., Simpson M., Skupski M.P., Smith T.J., RA Spier E., Spradling A.C., Stapleton M., Strong R., Sun E., RA Svirskas R., Tector C., Turner R., Venter E., Wang A.H., Wang X., RA Wang Z.-Y., Wassarman D.A., Weinstock G.M., Weissenbach J., RA Williams S.M., Woodage T., Worley K.C., Wu D., Yang S., Yao Q.A., RA Ye J., Yeh R.-F., Zaveri J.S., Zhan M., Zhang G., Zhao Q., Zheng L., RA Zheng X.H., Zhong F.N., Zhong W., Zhou X., Zhu S.C., Zhu X., RA Smith H.O., Gibbs R.A., Myers E.W., Rubin G.M., Venter J.C.; RT "The genome sequence of Drosophila melanogaster."; RL Science 287:2185-2195(2000). RN [3] RP GENOME REANNOTATION. RX MEDLINE=22426069; PubMed=12537572; RA Misra S., Crosby M.A., Mungall C.J., Matthews B.B., Campbell K.S., RA Hradecky P., Huang Y., Kaminker J.S., Millburn G.H., Prochnik S.E., RA Smith C.D., Tupy J.L., Whitfield E.J., Bayraktaroglu L., Berman B.P., RA Bettencourt B.R., Celniker S.E., de Grey A.D.N.J., Drysdale R.A., RA Harris N.L., Richter J., Russo S., Schroeder A.J., Shu S.Q., RA Stapleton M., Yamada C., Ashburner M., Gelbart W.M., Rubin G.M., RA Lewis S.E.; RT "Annotation of the Drosophila melanogaster euchromatic genome: a RT systematic review."; RL Genome Biol. 3:RESEARCH0083.1-RESEARCH0083.22(2002). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Berkeley; TISSUE=Embryo; RX MEDLINE=22426066; PubMed=12537569; RA Stapleton M., Carlson J.W., Brokstein P., Yu C., Champe M., RA George R.A., Guarin H., Kronmiller B., Pacleb J.M., Park S., Wan K.H., RA Rubin G.M., Celniker S.E.; RT "A Drosophila full-length cDNA resource."; RL Genome Biol. 3:RESEARCH0080.1-RESEARCH0080.8(2002). CC -!- FUNCTION: Essential for viability. CC -!- SUBCELLULAR LOCATION: Membrane; multi-pass membrane protein CC (Potential). DR EMBL; M62975; AAD40352.2; -; Genomic_DNA. DR EMBL; AE014297; AAF55023.1; -; Genomic_DNA. DR EMBL; AY058577; AAL13806.1; -; mRNA. DR PIR; JQ1024; JQ1024. DR UniGene; Dm.10056; -. DR Ensembl; CG9852; Drosophila melanogaster. DR KEGG; dme:Dmel_CG9852; -. DR FlyBase; FBgn0010340; 140up. DR BioCyc; DMEL-XXX-02:DMEL-XXX-02-011545-MONOMER; -. DR GermOnline; CG9852; Drosophila melanogaster. DR GO; GO:0007275; P:multicellular organismal development; IMP:UniProtKB. DR InterPro; IPR003397; Tim17_Tim22. DR Pfam; PF02466; Tim17; 1. KW Complete proteome; Membrane; Transmembrane. FT CHAIN 1 261 RPII140-upstream gene protein. FT /FTId=PRO_0000064352. FT TRANSMEM 67 87 Potential. FT TRANSMEM 131 151 Potential. FT TRANSMEM 183 203 Potential. FT CONFLICT 64 64 S -> F (in Ref. 1). SQ SEQUENCE 261 AA; 29182 MW; 5DB78CF6CFC4435A CRC64; MNFLWKGRRF LIAGILPTFE GAADEIVDKE NKTYKAFLAS KPPEETGLER LKQMFTIDEF GSISSELNSV YQAGFLGFLI GAIYGGVTQS RVAYMNFMEN NQATAFKSHF DAKKKLQDQF TVNFAKGGFK WGWRVGLFTT SYFGIITCMS VYRGKSSIYE YLAAGSITGS LYKVSLGLRG MAAGGIIGGF LGGVAGVTSL LLMKASGTSM EEVRYWQYKW RLDRDENIQQ AFKKLTEDEN PELFKAHDEK TSEHVSLDTI K // ID 14KD_DAUCA Reviewed; 137 AA. AC P14009; DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1990, sequence version 1. DT 01-MAY-2007, entry version 43. DE 14 kDa proline-rich protein DC2.15 precursor. OS Daucus carota (Carrot). OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta; OC Spermatophyta; Magnoliophyta; eudicotyledons; core eudicotyledons; OC asterids; campanulids; Apiales; Apiaceae; Apioideae; Scandiceae; OC Daucinae; Daucus. OX NCBI_TaxID=4039; RN [1] RP NUCLEOTIDE SEQUENCE. RA Aleith F., Richter G.; RT "Gene expression during induction of somatic embryogenesis in carrot RT cell suspensions."; RL Planta 183:17-24(1990). RN [2] RP NUCLEOTIDE SEQUENCE OF 1-8. RA Kaldenhoff R., Holk A., Richter G.; RL Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: May be connected with the initiation of embryogenesis or CC with the metabolic changes produced by the removal of auxins. CC -!- DEVELOPMENTAL STAGE: Transiently expressed during early CC embryogenesis. CC -!- INDUCTION: By the removal of auxins. DR EMBL; X15436; CAA33476.1; -; mRNA. DR EMBL; X75806; CAA53441.1; -; Genomic_DNA. DR EMBL; X75807; CAA53442.1; -; Genomic_DNA. DR EMBL; X75808; CAA53443.1; -; Genomic_DNA. DR EMBL; X75809; CAA53444.1; -; Genomic_DNA. DR EMBL; X75810; CAA53445.1; -; Genomic_DNA. DR PIR; S35714; S35714. DR HSSP; P24337; 1HYP. DR InterPro; IPR013770; LPT_helical. DR InterPro; IPR003612; LTP/seed_store/tryp_amyl_inhib. DR Gene3D; G3DSA:1.10.110.10; LPT_helical; 1. DR Pfam; PF00234; Tryp_alpha_amyl; 1. DR SMART; SM00499; AAI; 1. KW Membrane; Signal; Transmembrane. FT SIGNAL 1 25 Potential. FT CHAIN 26 137 14 kDa proline-rich protein DC2.15. FT /FTId=PRO_0000020572. FT TRANSMEM 88 104 Potential. FT COMPBIAS 30 49 Pro-rich. SQ SEQUENCE 137 AA; 14392 MW; CAED1BDB3949F890 CRC64; MGSKNSASVA LFFTLNILFF ALVSSTEKCP DPYKPKPKPT PKPTPTPYPS AGKCPRDALK LGVCADVLNL VHNVVIGSPP TLPCCSLLEG LVNLEAAVCL CTAIKANILG KNLNLPIALS LVLNNCGKQV PNGFECT // ID 14KD_RHOSH Reviewed; 124 AA. AC P16536; DT 01-AUG-1990, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 2. DT 31-OCT-2006, entry version 35. DE 14 kDa peptide of ubiquinol-cytochrome c2 oxidoreductase complex. OS Rhodobacter sphaeroides (Rhodopseudomonas sphaeroides). OC Bacteria; Proteobacteria; Alphaproteobacteria; Rhodobacterales; OC Rhodobacteraceae; Rhodobacter. OX NCBI_TaxID=1063; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX MEDLINE=91340695; PubMed=1651916; RA Usui S., Yu L.; RT "Subunit IV (Mr = 14,384) of the cytochrome b-c1 complex from RT Rhodobacter sphaeroides. Cloning, DNA sequencing, and ubiquinone RT binding domain."; RL J. Biol. Chem. 266:15644-15649(1991). RN [2] RP PROTEIN SEQUENCE OF 61-108. RX MEDLINE=90110107; PubMed=2153104; RA Purvis D.J., Theiler R., Niederman R.A.; RT "Chromatographic and protein chemical analysis of the ubiquinol- RT cytochrome c2 oxidoreductase isolated from Rhodobacter sphaeroides."; RL J. Biol. Chem. 265:1208-1215(1990). CC -!- FUNCTION: Component of the ubiquinol-cytochrome c reductase CC complex (complex III or cytochrome b-c1 complex), which is a CC respiratory chain that generates an electrochemical potential CC coupled to ATP synthesis. DR EMBL; M68939; AAA26107.1; -; Genomic_DNA. DR PIR; A40794; A40794. KW Direct protein sequencing; Electron transport; Inner membrane; KW Membrane; Oxidoreductase; Respiratory chain; Transmembrane; Transport. FT CHAIN 1 124 14 kDa peptide of ubiquinol-cytochrome c2 FT oxidoreductase complex. FT /FTId=PRO_0000064353. FT TRANSMEM 85 102 Potential. SQ SEQUENCE 124 AA; 14393 MW; E390C856C1D752F3 CRC64; MFSFIDDIPS FEQIKARVRD DLRKHGWEKR WNDSRLVQKS RELLNDEELK IDPATWIWKR MPSREEVAAR RQRDFETVWK YRYRLGGFAS GALLALALAG IFSTGNFGGS SDAGNRPSVV YPIE // ID 1A01_GORGO Reviewed; 365 AA. AC P30375; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 49. DE Class I histocompatibility antigen, GOGO-A0101 alpha chain precursor. OS Gorilla gorilla gorilla (Lowland gorilla). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Gorilla. OX NCBI_TaxID=9595; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=92078860; PubMed=1744581; DOI=10.1084/jem.174.6.1491; RA Lawlor D.A., Warren E., Taylor P., Parham P.; RT "Gorilla class I major histocompatibility complex alleles: comparison RT to human and chimpanzee class I."; RL J. Exp. Med. 174:1491-1509(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X60258; CAA42810.1; -; mRNA. DR PIR; JH0534; JH0534. DR HSSP; P10315; 1HSB. DR SMR; P30375; 25-299. DR InterPro; IPR013151; Ig. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF00047; ig; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 Class I histocompatibility antigen, GOGO- FT A0101 alpha chain. FT /FTId=PRO_0000018897. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 297 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40830 MW; FB1B14BCD4DF63A8 CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAHSQTDRV DLGTLRGYYN QSEDGSHTIQ RMYGCDVGSD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAEITKRK WEAAHFAEQL RAYLEGTCVE WLRRHLENGK ETLQRTDAPK THMTHHAVSD HEAILRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL PEPLTLRWEP SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A01_HUMAN Reviewed; 365 AA. AC P30443; O77964; O78171; Q9MYA3; Q9TP25; Q9TQP5; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 67. DE HLA class I histocompatibility antigen, A-1 alpha chain precursor (MHC DE class I antigen A*1). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*0101). RX MEDLINE=88234547; PubMed=3375250; RA Parham P., Lomen C.E., Lawlor D.A., Ways J.P., Holmes N., Coppin H.L., RA Salter R.D., Wan A.M., Ennis P.D.; RT "Nature of polymorphism in HLA-A, -B, and -C molecules."; RL Proc. Natl. Acad. Sci. U.S.A. 85:4005-4009(1988). RN [2] RP NUCLEOTIDE SEQUENCE (ALLELE A*0101). RX MEDLINE=89235215; PubMed=2715640; RA Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.; RT "Diversity and diversification of HLA-A,B,C alleles."; RL J. Immunol. 142:3937-3950(1989). RN [3] RP NUCLEOTIDE SEQUENCE (ALLELE A*0101). RA Warren E.; RL Submitted (APR-1989) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*0101). RX MEDLINE=91067475; PubMed=2251137; DOI=10.1093/nar/18.22.6701; RA Girdlestone J.; RT "Nucleotide sequence of an HLA-A1 gene."; RL Nucleic Acids Res. 18:6701-6701(1990). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*0101). RX MEDLINE=98007773; PubMed=9349617; RA Laforet M., Froelich N., Parissiadis A., Pfeiffer B., Schell A., RA Faller B., Woehl-Jaegle M.L., Cazenave J.-P., Tongio M.M.; RT "A nucleotide insertion in exon 4 is responsible for the absence of RT expression of an HLA-A*01 allele."; RL Tissue Antigens 50:347-350(1997). RN [6] RP NUCLEOTIDE SEQUENCE (ALLELE A*0101). RA Waller M.J., Robinson J., Marsh S.G.E.; RL Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE A*0101). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*0102). RX MEDLINE=95282145; PubMed=7761977; RA Browning M.J., Madrigal J.A., Krausa P., Kowalski H., Allsopp C.E., RA Little A.-M., Turner S., Adams E.J., Arnett K.L., Bodmer W.F., RA Parham P.; RT "The HLA-A,B,C genotype of the class I negative cell line Daudi RT reveals novel HLA-A and -B alleles."; RL Tissue Antigens 45:177-187(1995). RN [9] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*0103). RX MEDLINE=98101100; PubMed=9438203; DOI=10.1016/S0198-8859(97)00204-8; RA Sitha S., Scheltinga S.A., Johnston-Dow L.A., White C.B., RA der van Zwan A.W., Bakema J.E., Rozemuller E.H., van der Tweel J.G., RA Kronink M.N., Tilanus M.G.J.; RT "A generic sequencing based typing approach for the identification of RT HLA-A diversity."; RL Hum. Immunol. 57:120-128(1997). RN [10] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*0103). RC TISSUE=Blood; RX MEDLINE=21100775; PubMed=11182232; DOI=10.1016/S0198-8859(00)00238-X; RA Poland G.A., Sohni Y., Domanico M., Kroning C.M., DeGoey S.R., RA Jimale M., Jacobson R.M., Moore S.B.; RT "High frequency of HLA-A*0103 allele in a Somali population."; RL Hum. Immunol. 62:197-200(2001). RN [11] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*0106). RX MEDLINE=20309230; PubMed=10852390; RX DOI=10.1034/j.1399-0039.2000.550412.x; RA Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R., RA Ng J., Hartzman R.J., Hurley C.K.; RT "Seventeen more novel HLA-A locus alleles."; RL Tissue Antigens 55:369-373(2000). RN [12] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*0107). RA Tamouza R., Fortier C., Mahfoudh N., Schaeffer V., Poirier J.C., RA Marzais F., Gautreau C., Charron D.; RT "A new HLA-A*01 allele."; RL Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases. RN [13] RP SULFATION. RX MEDLINE=88088800; PubMed=3121736; RA Sant A.J., Zacheis M., Rumbarger T., Giacoletto K.S., Schwartz B.D.; RT "Human Ia alpha- and beta-chains are sulfated."; RL J. Immunol. 140:155-160(1988). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Dimer of alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Sulfated. Polyubiquitinated in a post ER compartment through CC interaction with human herpesvirus 8 MIR1 protein. This targets CC the protein for rapid degradation via the ubiquitin system (By CC similarity). CC -!- POLYMORPHISM: The following alleles of A-1 are known: A*0101, CC A*0102, A*0103, A*0106 and A*0107. The sequence shown is that of CC A*0101. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M24043; AAA59652.1; -; Genomic_DNA. DR EMBL; X55710; CAA39243.1; -; Genomic_DNA. DR EMBL; Z93949; CAB07989.1; -; Genomic_DNA. DR EMBL; AJ278305; CAB93537.1; -; Genomic_DNA. DR EMBL; BC003069; AAH03069.1; -; mRNA. DR EMBL; U07161; AAA80569.1; -; mRNA. DR EMBL; Y12469; CAA73072.1; -; Genomic_DNA. DR EMBL; Y12470; CAA73073.1; -; Genomic_DNA. DR EMBL; AF214112; AAF19525.1; -; Genomic_DNA. DR EMBL; AF214111; AAF19525.1; JOINED; Genomic_DNA. DR EMBL; AF143232; AAD33894.1; -; Genomic_DNA. DR EMBL; AF143231; AAD33894.1; JOINED; Genomic_DNA. DR EMBL; AF219633; AAF73862.1; -; Genomic_DNA. DR EMBL; AF219632; AAF73862.1; JOINED; Genomic_DNA. DR PIR; I38518; I38518. DR PIR; I61856; I61856. DR UniGene; Hs.181244; -. DR PDB; 1W72; X-ray; A/D=25-298. DR Ensembl; ENSG00000206441; Homo sapiens. DR H-InvDB; HIX0005684; -. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR LinkHub; P30443; -. DR GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB. DR GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB. DR GO; GO:0006955; P:immune response; NAS:UniProtKB. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW 3D-structure; Glycoprotein; Host-virus interaction; Immune response; KW Immunoglobulin domain; Membrane; MHC I; Polymorphism; Signal; KW Sulfation; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-1 alpha chain. FT /FTId=PRO_0000018813. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT MOD_RES 83 83 Sulfotyrosine (Potential). FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 33 33 F -> S (in allele A*0102). FT /FTId=VAR_004332. FT VARIANT 41 41 R -> S (in allele A*0102). FT /FTId=VAR_004333. FT VARIANT 80 80 G -> R (in allele A*0107). FT /FTId=VAR_016719. FT VARIANT 91 91 M -> V (in allele A*0107). FT /FTId=VAR_016720. FT VARIANT 100 100 A -> E (in allele A*0107). FT /FTId=VAR_016721. FT VARIANT 114 114 D -> A (in allele A*0107). FT /FTId=VAR_016722. FT VARIANT 121 121 I -> M (in allele A*0103). FT /FTId=VAR_016723. FT VARIANT 180 180 R -> L (in allele A*0106). FT /FTId=VAR_016724. FT VARIANT 182 182 V -> A (in allele A*0106). FT /FTId=VAR_016725. FT STRAND 27 38 FT TURN 39 41 FT STRAND 42 52 FT STRAND 55 61 FT STRAND 70 73 FT HELIX 74 78 FT HELIX 81 108 FT STRAND 113 115 FT STRAND 118 127 FT STRAND 133 142 FT STRAND 145 150 FT STRAND 157 161 FT HELIX 162 173 FT HELIX 176 185 FT HELIX 187 198 FT HELIX 200 203 FT STRAND 210 217 FT STRAND 219 235 FT STRAND 238 243 FT STRAND 250 254 FT STRAND 261 263 FT STRAND 265 274 FT HELIX 278 280 FT STRAND 281 286 FT STRAND 294 297 SQ SEQUENCE 365 AA; 40846 MW; 8667AFF3F06C4932 CRC64; MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQKME PRAPWIEQEG PEYWDQETRN MKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAVHAAEQR RVYLEGRCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL TACKV // ID 1A01_PANTR Reviewed; 365 AA. AC P16209; Q549C1; DT 01-APR-1990, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1990, sequence version 1. DT 01-MAY-2007, entry version 52. DE CHLA class I histocompatibility antigen, A-2 alpha chain precursor. OS Pan troglodytes (Chimpanzee). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pan. OX NCBI_TaxID=9598; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=90201944; PubMed=1690682; RA Lawlor D.A., Warren E., Ward F.E., Parham P.; RT "Comparison of class I MHC alleles in humans and apes."; RL Immunol. Rev. 113:147-185(1990). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Blood; RX MEDLINE=20322475; PubMed=10866106; DOI=10.1007/s002510050638; RA de Groot N.G., Otting N., Arguello R., Watkins D.I., Doxiadis G.G., RA Madrigal J.A., Bontrop R.E.; RT "Major histocompatibility complex class I diversity in a West African RT chimpanzee population: implications for HIV research."; RL Immunogenetics 51:398-409(2000). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M30678; AAA87970.1; -; mRNA. DR EMBL; AF168394; AAF72775.1; -; mRNA. DR PIR; I36961; I36961. DR HSSP; P10315; 1HSB. DR SMR; P16209; 25-299. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 CHLA class I histocompatibility antigen, FT A-2 alpha chain. FT /FTId=PRO_0000018910. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40849 MW; FC452786BD038D3E CRC64; MAVMPPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDEETRS AKAHSQTDRV DLGTLRGYYN QSEDGSHTIQ IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHAAEQR RAYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL TACKV // ID 1A01_PONPY Reviewed; 365 AA. AC P16211; DT 01-APR-1990, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1990, sequence version 1. DT 01-MAY-2007, entry version 51. DE Class I histocompatibility antigen, A-1 alpha chain precursor. OS Pongo pygmaeus (Orangutan). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pongo. OX NCBI_TaxID=9600; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=90201944; PubMed=1690682; RA Lawlor D.A., Warren E., Ward F.E., Parham P.; RT "Comparison of class I MHC alleles in humans and apes."; RL Immunol. Rev. 113:147-185(1990). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M30680; AAA88835.1; -; mRNA. DR PIR; I84432; I84432. DR HSSP; P10315; 1HSB. DR SMR; P16211; 25-299. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 Class I histocompatibility antigen, A-1 FT alpha chain. FT /FTId=PRO_0000018918. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 297 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40658 MW; 11A5BC183009CF70 CRC64; MAIMAPRTLL LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRTPWMEQEG PEYWDRETRS VKAHAQTNRV DLGTLRGYYN QSDGGSHTIQ RMFGCDVGPD GRFLRGYEQH AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAAGAAEQD RAYLEGLCVE SLRRYLENGK ETLQRTDAPK THMTHHPVSD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGKEQR YTCHVQHEGL PEPLTLRWEL SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRRNSDRK GGSYSQAASN DSAQGSDVSL TACKV // ID 1A01_SAGOE Reviewed; 365 AA. AC P30515; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 46. DE Class I histocompatibility antigen, A alpha chain precursor. OS Saguinus oedipus (Cotton-top tamarin). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Platyrrhini; Cebidae; Callitrichinae; Saguinus. OX NCBI_TaxID=9490; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=90111120; PubMed=2104912; RA Watkins D.I., Letvin N.L., Hughes A.L., Tedder T.F.; RT "Molecular cloning of cDNA that encode MHC class I molecules from a RT New World primate (Saguinus oedipus). Natural selection acts at RT positions that may affect peptide presentation to T cells."; RL J. Immunol. 144:1136-1143(1990). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M33475; AAA36951.1; -; mRNA. DR PIR; I56053; I56053. DR HSSP; Q29961; 1HSA. DR SMR; P30515; 25-299. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 Class I histocompatibility antigen, A FT alpha chain. FT /FTId=PRO_0000018920. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 297 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40973 MW; B34B24FB6848E373 CRC64; MTVMAPRTLL LLLSGALVLT ETWAGSHSMR YFETSVSRPG RGEPRYISVG YVDDTQFVRF DSDAASPRME PRAPWMEQEG PEYWEEETRK GKADAQTFRV DLQTLLGYYN QSEAGSHTIQ WMYGCDLGPD GRLLRGYDQH AYDGKDYIAL NEDLRSWTAT DVAAQITQRK WEAANEAERT RAYLEGTCVE WLHRYLENGK ETLQRAEPPK THVTHHPVSD HEATLRCWAL GFYPAEITVT WQRDGEDQTQ DMELVETRPA GDGTFQKWAA VVVLSGEEQR YTCHVQHEGL PEPLTLRWEP PSQPTIPIMG IVAILAILGV VVTGAVVAAV MWRKKSSDKK GGSYSQAARS DSAQGSDVSL TACKV // ID 1A02_GORGO Reviewed; 365 AA. AC P30376; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 47. DE Class I histocompatibility antigen, GOGO-A0201 alpha chain precursor. OS Gorilla gorilla gorilla (Lowland gorilla). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Gorilla. OX NCBI_TaxID=9595; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=92078860; PubMed=1744581; DOI=10.1084/jem.174.6.1491; RA Lawlor D.A., Warren E., Taylor P., Parham P.; RT "Gorilla class I major histocompatibility complex alleles: comparison RT to human and chimpanzee class I."; RL J. Exp. Med. 174:1491-1509(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X60259; CAA42811.1; -; mRNA. DR PIR; JH0535; JH0535. DR HSSP; P10315; 1HSB. DR SMR; P30376; 25-300. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 Class I histocompatibility antigen, GOGO- FT A0201 alpha chain. FT /FTId=PRO_0000018898. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40896 MW; 09E0E5FCD8E58507 CRC64; MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEE PEYWDGETRK VKAHSQTDRV NLGTLRGYYN QSEAGSHTIQ KMYGCDVGSD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAEITKRK WEAAHFAEQL RAYLEGECVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEAILRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHESL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VIAGAVIAAV RWRRKSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A02_HUMAN Reviewed; 365 AA. AC P01892; O19619; P06338; P10313; P30444; P30445; P30446; P30514; AC Q29680; Q29837; Q29899; Q95352; Q95380; Q9TPX8; Q9TPX9; Q9TPY0; AC Q9TQH5; Q9TQI3; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 13-AUG-1987, sequence version 1. DT 01-MAY-2007, entry version 87. DE HLA class I histocompatibility antigen, A-2 alpha chain precursor (MHC DE class I antigen A*2). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*0201). RX MEDLINE=85132727; PubMed=2982951; RA Koller B.H., Orr H.T.; RT "Cloning and complete sequence of an HLA-A2 gene: analysis of two HLA- RT A alleles at the nucleotide level."; RL J. Immunol. 134:2727-2733(1985). RN [2] RP NUCLEOTIDE SEQUENCE (ALLELE A*0201). RX MEDLINE=89122144; PubMed=2914713; RA Cianetti L., Testa U., Scotto L., la Valle R., Simeone A., Boccoli G., RA Giannella G., Peschle C., Boncinelli E.; RT "Three new class I HLA alleles: structure of mRNAs and alternative RT mechanisms of processing."; RL Immunogenetics 29:80-91(1989). RN [3] RP NUCLEOTIDE SEQUENCE (ALLELE A*0201). RX MEDLINE=90207291; PubMed=2320591; RA Ennis P.D., Zemmour J., Salter R.D., Parham P.; RT "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: RT frequency and nature of errors produced in amplification."; RL Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 91-365. RX MEDLINE=86033791; PubMed=3863816; RA Davidson W.F., Kress M., Khoury G., Jay G.; RT "Comparison of HLA class I gene sequences. Derivation of locus- RT specific oligonucleotide probes specific for HLA-A, HLA-B, and HLA-C RT genes."; RL J. Biol. Chem. 260:13414-13423(1985). RN [5] RP NUCLEOTIDE SEQUENCE (ALLELES A*0201; A*0211 AND A*0212). RX MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0; RA Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J., RA Williams R.C., Luz R., Petzl-Erler M.L., Parham P.; RT "Unusual HLA-B alleles in two tribes of Brazilian Indians."; RL Nature 357:326-329(1992). RN [6] RP NUCLEOTIDE SEQUENCE [MRNA] OF 39-365 (ALLELE A*0201). RX MEDLINE=85230571; PubMed=3874058; RA Krangel M.S.; RT "Unusual RNA splicing generates a secreted form of HLA-A2 in a RT mutagenized B lymphoblastoid cell line."; RL EMBO J. 4:1205-1210(1985). RN [7] RP PROTEIN SEQUENCE OF 25-295 (A*0201). RX MEDLINE=80056745; PubMed=92029; RA Orr H.T., Lopez de Castro J.A., Parham P., Ploegh H.L., RA Strominger J.L.; RT "Comparison of amino acid sequences of two human histocompatibility RT antigens, HLA-A2 and HLA-B7: location of putative alloantigenic RT sites."; RL Proc. Natl. Acad. Sci. U.S.A. 76:4395-4399(1979). RN [8] RP SEQUENCE REVISION (A*0201). RX MEDLINE=82247941; PubMed=6179086; RA Lopez de Castro J.A., Strominger J.L., Strong D.M., Orr H.T.; RT "Structure of crossreactive human histocompatibility antigens HLA-A28 RT and HLA-A2: possible implications for the generation of HLA RT polymorphism."; RL Proc. Natl. Acad. Sci. U.S.A. 79:3813-3817(1982). RN [9] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*0201). RC TISSUE=Blood; RX MEDLINE=95137784; PubMed=7836067; DOI=10.1016/0198-8859(94)90087-6; RA Balas A., Garcia-Sanchez F., Gomez-Reino F., Vicario J.L.; RT "HLA class I allele (HLA-A2) expression defect associated with a RT mutation in its enhancer B inverted CAT box in two families."; RL Hum. Immunol. 41:69-73(1994). RN [10] RP SEQUENCE REVISION. RA Balas A.; RL Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases. RN [11] RP NUCLEOTIDE SEQUENCE (ALLELE A*0201). RA Cox S.T.; RT "Confirmation of HLA-A*0201."; RL Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases. RN [12] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-298 (ALLELES A*0202 AND RP A*0203). RX MEDLINE=87306734; PubMed=3497874; RA Mattson D.H., Handy D.E., Bradley D.A., Coligan J.E., Cowan E.P., RA Biddison W.E.; RT "DNA sequences of the genes that encode the CTL-defined HLA-A2 RT variants M7 and DK1."; RL Immunogenetics 26:190-192(1987). RN [13] RP NUCLEOTIDE SEQUENCE (ALLELES A*0203 AND A*0205). RX MEDLINE=87252273; PubMed=3496393; RA Holmes N., Ennis P., Wan A.M., Denney D.W., Parham P.; RT "Multiple genetic mechanisms have contributed to the generation of the RT HLA-A2/A28 family of class I MHC molecules."; RL J. Immunol. 139:936-941(1987). RN [14] RP NUCLEOTIDE SEQUENCE (ALLELES A*0203 AND A*0205). RA Domena J.D.; RL Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases. RN [15] RP NUCLEOTIDE SEQUENCE [MRNA] OF 9-365 (ALLELE A*0204). RX MEDLINE=92039809; PubMed=1937577; DOI=10.1007/BF00211991; RA Castano A.R., Lopez de Castro J.A.; RT "Structure of the HLA-A*0204 antigen, found in South American Indians. RT Spatial clustering of HLA-A2 subtype polymorphism."; RL Immunogenetics 34:281-285(1991). RN [16] RP NUCLEOTIDE SEQUENCE OF 9-365 (ALLELE A*0204). RX MEDLINE=92269956; PubMed=1589035; DOI=10.1038/357329a0; RA Watkins D.I., McAdam S.N., Liu X., Stang C.R., Milford E.L., RA Levine C.G., Garber T.L., Dogon A.L., Lord C.I., Ghim S.H., RA Troup G.M., Hughes A.L., Letvin N.L.; RT "New recombinant HLA-B alleles in a tribe of South American RT Amerindians indicate rapid evolution of MHC class I loci."; RL Nature 357:329-333(1992). RN [17] RP NUCLEOTIDE SEQUENCE (ALLELE A*0206). RX MEDLINE=89235215; PubMed=2715640; RA Parham P., Lawlor D.A., Lomen C.E., Ennis P.D.; RT "Diversity and diversification of HLA-A,B,C alleles."; RL J. Immunol. 142:3937-3950(1989). RN [18] RP PARTIAL PROTEIN SEQUENCE (A*0206). RX MEDLINE=86305811; PubMed=3489037; RA Ezquerra A., Domenech N., van der Poel J., Strominger J.L., Vega M.A., RA Lopez de Castro J.A.; RT "Molecular analysis of an HLA-A2 functional variant CLA defined by RT cytolytic T lymphocytes."; RL J. Immunol. 137:1642-1649(1986). RN [19] RP PARTIAL PROTEIN SEQUENCE (A*0207). RX MEDLINE=88113844; PubMed=2448239; RA Domenech N., Ezquerra A., Castano R., Lopez de Castro J.A.; RT "Structural analysis of HLA-A2.4 functional variant KNE. Implications RT for the mapping of HLA-A2-specific T-cell epitopes."; RL Immunogenetics 27:196-202(1988). RN [20] RP PARTIAL PROTEIN SEQUENCE (A*0208). RX MEDLINE=88314183; PubMed=2457548; RA Domenech N., Castano R., Goulmy E., Lopez de Castro J.A.; RT "Molecular analysis of HLA-A2.4 functional variant KLO: close RT structural and evolutionary relatedness to the HLA-A2.2 subtype."; RL Immunogenetics 28:143-152(1988). RN [21] RP PARTIAL PROTEIN SEQUENCE (A*0209). RX MEDLINE=88186100; PubMed=3258580; RA Castano R., Ezquerra A., Domenech N., Lopez de Castro J.A.; RT "An HLA-A2 population variant with structural polymorphism in the RT alpha 3 region."; RL Immunogenetics 27:345-355(1988). RN [22] RP NUCLEOTIDE SEQUENCE (ALLELE A*0210). RX MEDLINE=89122133; PubMed=2783680; RA Epstein H., Kennedy L., Holmes N.; RT "An Oriental HLA-A2 subtype is closely related to a subset of RT Caucasoid HLA-A2 alleles."; RL Immunogenetics 29:112-116(1989). RN [23] RP NUCLEOTIDE SEQUENCE [MRNA] OF 9-365 (ALLELE A*0211). RX MEDLINE=92218010; PubMed=1559719; DOI=10.1007/BF00189898; RA Castano A.R., Lopez de Castro J.A.; RT "Structure of the HLA-A*0211 (A2.5) subtype: further evidence for RT selection-driven diversification of HLA-A2 antigens."; RL Immunogenetics 35:344-346(1992). RN [24] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*0213). RX MEDLINE=94222455; PubMed=8168863; DOI=10.1007/BF00189243; RA Barber D.F., Fernandez J.M., Lopez de Castro J.A.; RT "Primary structure of a new HLA-A2 subtype: HLA-A*0213."; RL Immunogenetics 39:378-378(1994). RN [25] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*0216). RX MEDLINE=95278976; PubMed=7759139; RA Barouch D., Krausa P., Bodmer J., Browning M.J., McMichael A.J.; RT "Identification of a novel HLA-A2 subtype, HLA-A*0216."; RL Immunogenetics 41:388-388(1995). RN [26] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*0217). RC TISSUE=Blood; RX MEDLINE=95381236; PubMed=7652742; RA Selvakumar A., Granja C.B., Salazar M., Alosco S.M., Yunis E.J., RA Dupont B.; RT "A novel subtype of A2 (A*0217) isolated from the South American RT Indian B-cell line AMALA."; RL Tissue Antigens 45:343-347(1995). RN [27] RP NUCLEOTIDE SEQUENCE (ALLELE A*0218). RC TISSUE=Blood; RA Kashiwase K., Tokunaga K., Ishikawa Y., Oohashi H., Hashimoto M., RA Akaza T., Tadokoro K., Juji T.; RT "A new A2 sequence HLA-A2K from Japanese."; RL Submitted (FEB-1996) to the EMBL/GenBank/DDBJ databases. RN [28] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*0220). RC TISSUE=Blood; RX MEDLINE=97161038; PubMed=9008310; RA Fleischhauer K., Zino E., Mazzi B., Severini G.M., Benazzi E., RA Bordignon C.; RT "HLA-A*02 subtype distribution in Caucasians from northern Italy: RT identification of A*0220."; RL Tissue Antigens 48:673-679(1996). RN [29] RP NUCLEOTIDE SEQUENCE (ALLELE A*0221). RC TISSUE=Blood; RA Szmania S., Baxter-Lowe L.A.; RT "Nucleotide sequence of a novel HLA-A2 gene."; RL Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases. RN [30] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*0231). RX MEDLINE=20156437; PubMed=10689125; DOI=10.1016/S0198-8859(99)00155-X; RA Ellis J.M., Henson V., Slack R., Ng J., Hartzman R.J., RA Katovich Hurley C.; RT "Frequencies of HLA-A2 alleles in five U.S. population groups. RT Predominance Of A*02011 and identification of HLA-A*0231."; RL Hum. Immunol. 61:334-340(2000). RN [31] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-298 (ALLELE A*0234). RX MEDLINE=20208581; PubMed=10746792; RX DOI=10.1034/j.1399-0039.2000.550212.x; RA Moses J.H., Greville W.D., Downes J., McClenahan W., Kennedy A., RA Dunckley H.; RT "A new HLA-A*02 allele, A*0234, detected by polymerase chain reaction RT using sequence-specific primers (PCR-SSP)."; RL Tissue Antigens 55:175-177(2000). RN [32] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*0235; A*0236 AND A*0237). RX MEDLINE=20309230; PubMed=10852390; RX DOI=10.1034/j.1399-0039.2000.550412.x; RA Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R., RA Ng J., Hartzman R.J., Hurley C.K.; RT "Seventeen more novel HLA-A locus alleles."; RL Tissue Antigens 55:369-373(2000). RN [33] RP X-RAY CRYSTALLOGRAPHY (3.5 ANGSTROMS) OF A*0201. RX MEDLINE=88014204; PubMed=3309677; DOI=10.1038/329506a0; RA Bjorkman P.J., Saper M.A., Samraoui B., Bennett W.S., Strominger J.L., RA Wiley D.C.; RT "Structure of the human class I histocompatibility antigen, HLA-A2."; RL Nature 329:506-512(1987). RN [34] RP INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P12I. RX PubMed=11390610; DOI=10.1128/JVI.75.13.6086-6094.2001; RA Johnson J.M., Nicot C., Fullen J., Ciminale V., Casareto L., RA Mulloy J.C., Jacobson S., Franchini G.; RT "Free major histocompatibility complex class I heavy chain is RT preferentially targeted for degradation by human T-cell RT leukemia/lymphotropic virus type 1 p12(I) protein."; RL J. Virol. 75:6086-6094(2001). RN [35] RP INTERACTION WITH HUMAN HERPESVIRUS 8 MIR1 PROTEIN. RX PubMed=12006494; DOI=10.1093/emboj/21.10.2418; RA Hewitt E.W., Duncan L., Mufti D., Baker J., Stevenson P.G., RA Lehner P.J.; RT "Ubiquitylation of MHC class I by the K3 viral protein signals RT internalization and TSG101-dependent degradation."; RL EMBO J. 21:2418-2429(2002). RN [36] RP X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF A*0201. RX MEDLINE=91245570; PubMed=2038058; DOI=10.1016/0022-2836(91)90567-P; RA Saper M.A., Bjorkman P.J., Wiley D.C.; RT "Refined structure of the human histocompatibility antigen HLA-A2 at RT 2.6-A resolution."; RL J. Mol. Biol. 219:277-319(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Dimer of alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein. CC Interacts with HTLV-1 accessory protein p12I. CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment through CC interaction with human herpesvirus 8 MIR1 protein. This targets CC the protein for rapid degradation via the ubiquitin system. CC -!- POLYMORPHISM: The following alleles of A-2 are known: A*0201, CC A*0202, A*0203, A*0204, A*0205, A*0206 (A2.4A), A*0207, A*0208, CC A*0209, A*0210, A*0211 (A2.5), A*0212, A*0213 (A*02SLU), A*0216, CC A*0217, A*0218 (A2K), A*0219, A*0220, A*0221, A*0231, A*0234 CC (A*AAT), A*0235, A*0236 and A*0237. The sequence shown is that of CC A*0201. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. CC -!- CAUTION: Ref.6 and Ref.7 sequences differ from that shown CC extensively. DR EMBL; K02883; AAA98727.1; -; Genomic_DNA. DR EMBL; M84379; AAA59606.1; -; mRNA. DR EMBL; X02457; CAA26297.1; -; mRNA. DR EMBL; M11887; AAA52656.1; -; mRNA. DR EMBL; M19670; AAA03683.2; -; Genomic_DNA. DR EMBL; M17690; AAB02120.1; -; Genomic_DNA. DR EMBL; U03863; AAA03604.1; -; Unassigned_DNA. DR EMBL; M86404; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; X57954; CAA41022.1; ALT_SEQ; mRNA. DR EMBL; U02935; AAA76608.2; -; Genomic_DNA. DR EMBL; AJ555412; CAD87771.1; -; Genomic_DNA. DR EMBL; U03862; AAA03603.1; -; Unassigned_DNA. DR EMBL; M24042; AAA59653.1; -; mRNA. DR EMBL; Z23071; CAA80612.1; -; mRNA. DR EMBL; M84377; AAA59603.1; -; mRNA. DR EMBL; X60764; -; NOT_ANNOTATED_CDS; mRNA. DR EMBL; M84378; AAA59604.1; -; mRNA. DR EMBL; Z27120; CAA81644.1; -; mRNA. DR EMBL; Z46633; CAA86602.1; -; mRNA. DR EMBL; U18930; AAA87076.1; -; mRNA. DR EMBL; D83515; BAA11935.1; -; mRNA. DR EMBL; X96724; CAA65501.1; -; mRNA. DR EMBL; U56825; AAB17465.1; -; mRNA. DR EMBL; AF113924; AAD23437.1; -; Genomic_DNA. DR EMBL; AF113923; AAD23437.1; JOINED; Genomic_DNA. DR EMBL; AF129431; AAD30272.1; -; Genomic_DNA. DR EMBL; AF129429; AAD30272.1; JOINED; Genomic_DNA. DR EMBL; AF129430; AAD30272.1; JOINED; Genomic_DNA. DR EMBL; AF157311; AAD45690.1; -; Genomic_DNA. DR EMBL; AF157310; AAD45690.1; JOINED; Genomic_DNA. DR EMBL; AF157309; AAD45689.1; -; Genomic_DNA. DR EMBL; AF157308; AAD45689.1; JOINED; Genomic_DNA. DR EMBL; AF157564; AAD45324.1; -; Genomic_DNA. DR EMBL; AF157563; AAD45324.1; JOINED; Genomic_DNA. DR PIR; B24512; HLHU10. DR PIR; I38418; I38418. DR PIR; I38442; I38442. DR PIR; I61857; I61857. DR UniGene; Hs.181244; -. DR PDB; 1AKJ; X-ray; A=25-300. DR PDB; 1AO7; X-ray; A=25-299. DR PDB; 1AQD; X-ray; C/F/I/L=127-141. DR PDB; 1B0G; X-ray; A/D=25-299. DR PDB; 1B0R; X-ray; A=25-299. DR PDB; 1BD2; X-ray; A=25-299. DR PDB; 1DUY; X-ray; A/D=25-299. DR PDB; 1DUZ; X-ray; A/D=25-299. DR PDB; 1EEY; X-ray; A/D=25-299. DR PDB; 1EEZ; X-ray; A/D=25-299. DR PDB; 1HHG; X-ray; A/D=25-299. DR PDB; 1HHH; X-ray; A=25-299. DR PDB; 1HHI; X-ray; A/D=25-299. DR PDB; 1HHJ; X-ray; A/D=25-299. DR PDB; 1HHK; X-ray; A/D=25-299. DR PDB; 1HLA; X-ray; A=25-294. DR PDB; 1I1F; X-ray; A/D=25-299. DR PDB; 1I1Y; X-ray; A/D=25-299. DR PDB; 1I4F; X-ray; A=25-299. DR PDB; 1I7R; X-ray; A/D=25-299. DR PDB; 1I7T; X-ray; A/D=25-299. DR PDB; 1I7U; X-ray; A/D=25-299. DR PDB; 1IM3; X-ray; A/E/I/M=25-299. DR PDB; 1JF1; X-ray; A=25-299. DR PDB; 1JHT; X-ray; A=25-299. DR PDB; 1LP9; X-ray; A/H=25-299. DR PDB; 1OGA; X-ray; A=25-300. DR PDB; 1P7Q; X-ray; A=25-300. DR PDB; 1QEW; X-ray; A=25-299. DR PDB; 1QR1; X-ray; A/D=25-299. DR PDB; 1QRN; X-ray; A=25-298. DR PDB; 1QSE; X-ray; A=25-298. DR PDB; 1QSF; X-ray; A=25-298. DR PDB; 1S9W; X-ray; A=25-298. DR PDB; 1S9X; X-ray; A=25-298. DR PDB; 1S9Y; X-ray; A=25-298. DR PDB; 1TVB; X-ray; A/D=25-299. DR PDB; 1TVH; X-ray; A/D=25-299. DR PDB; 1UR7; Model; A=25-299. DR PDB; 2AV1; X-ray; A/D=25-299. DR PDB; 2AV7; X-ray; A/D=25-299. DR PDB; 2BNQ; X-ray; A=25-300. DR PDB; 2BNR; X-ray; A=25-300. DR PDB; 2BSU; X-ray; A/D=25-300. DR PDB; 2BSV; X-ray; A/D=25-300. DR PDB; 2C7U; X-ray; A/D=25-300. DR PDB; 2CLR; X-ray; A/D=25-299. DR PDB; 2F53; X-ray; A=25-299. DR PDB; 2F54; X-ray; A/F=25-298. DR PDB; 3HLA; X-ray; A=25-294. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR LinkHub; P01892; -. DR ArrayExpress; P01892; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR GO; GO:0005515; F:protein binding; IPI:UniProtKB. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW 3D-structure; Direct protein sequencing; Glycoprotein; KW Host-virus interaction; Immune response; Membrane; MHC I; KW Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-2 alpha chain. FT /FTId=PRO_0000018814. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...). FT DISULFID 125 188 FT DISULFID 227 283 FT VARIANT 33 33 F -> Y (in allele A*0205, allele A*0206, FT allele A*0208, allele A*0210 and allele FT A*0221). FT /FTId=VAR_004334. FT VARIANT 54 54 D -> N (in allele A*0221). FT /FTId=VAR_004335. FT VARIANT 65 65 A -> G (in allele A*0231). FT /FTId=VAR_016726. FT VARIANT 67 67 Q -> R (in allele A*0202, allele A*0205 FT and allele A*0208). FT /FTId=VAR_004336. FT VARIANT 90 90 K -> N (in allele A*0208 and allele FT A*0220). FT /FTId=VAR_004337. FT VARIANT 94 94 H -> Q (in allele A*0234 and allele FT A*0235). FT /FTId=VAR_016727. FT VARIANT 97 97 T -> I (in allele A*0211). FT /FTId=VAR_004338. FT VARIANT 98 98 H -> D (in allele A*0211 and allele FT A*0235). FT /FTId=VAR_016728. FT VARIANT 119 119 V -> L (in allele A*0202, allele A*0205, FT allele A*0208 and allele A*0217). FT /FTId=VAR_004339. FT VARIANT 121 121 R -> M (in allele A*0204 and allele FT A*0217). FT /FTId=VAR_004340. FT VARIANT 123 123 Y -> C (in allele A*0207 and allele FT A*0218). FT /FTId=VAR_004341. FT VARIANT 123 123 Y -> F (in allele A*0210 and allele FT A*0217). FT /FTId=VAR_004342. FT VARIANT 131 131 W -> G (in allele A*0210). FT /FTId=VAR_004343. FT VARIANT 162 162 M -> K (in allele A*0218). FT /FTId=VAR_004344. FT VARIANT 173 173 A -> T (in allele A*0203). FT /FTId=VAR_004345. FT VARIANT 176 176 V -> E (in allele A*0203 and allele FT A*0213). FT /FTId=VAR_004346. FT VARIANT 180 180 L -> Q (in allele A*0212, allele A*0213 FT and allele A*0237). FT /FTId=VAR_004348. FT VARIANT 180 180 L -> W (in allele A*0202, allele A*0203, FT allele A*0205 and allele A*0208). FT /FTId=VAR_004347. FT VARIANT 187 187 T -> E (in allele A*0216; requires 2 FT nucleotide substitutions). FT /FTId=VAR_004349. FT VARIANT 190 190 E -> D (in allele A*0236 and allele FT A*0237). FT /FTId=VAR_016729. FT VARIANT 191 191 W -> G (in allele A*0236 and allele FT A*0237). FT /FTId=VAR_016730. FT VARIANT 260 260 A -> E (in allele A*0209). FT /FTId=VAR_004350. FT CONFLICT 115 115 G -> V (in Ref. 4). FT CONFLICT 140 140 Y -> V (in Ref. 4). FT CONFLICT 277 277 Q -> E (in Ref. 4). FT CONFLICT 318 318 F -> L (in Ref. 4). FT STRAND 23 32 FT STRAND 27 36 FT STRAND 41 43 FT STRAND 45 52 FT STRAND 55 61 FT STRAND 64 66 FT HELIX 74 76 FT HELIX 81 108 FT STRAND 113 115 FT STRAND 118 127 FT STRAND 131 142 FT STRAND 145 150 FT STRAND 154 161 FT HELIX 162 173 FT HELIX 176 184 FT HELIX 187 198 FT HELIX 200 203 FT STRAND 210 235 FT STRAND 238 243 FT STRAND 246 248 FT STRAND 252 254 FT STRAND 261 263 FT STRAND 265 274 FT HELIX 278 280 FT STRAND 281 286 FT STRAND 294 297 SQ SEQUENCE 365 AA; 40922 MW; B54A97B24B337C08 CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDGETRK VKAHSQTHRV DLGTLRGYYN QSEAGSHTVQ RMYGCDVGSD WRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQTTKHK WEAAHVAEQL RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A02_PANTR Reviewed; 362 AA. AC P16210; DT 01-APR-1990, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1990, sequence version 1. DT 01-MAY-2007, entry version 51. DE CHLA class I histocompatibility antigen, A-5 alpha chain precursor. OS Pan troglodytes (Chimpanzee). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pan. OX NCBI_TaxID=9598; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=90201944; PubMed=1690682; RA Lawlor D.A., Warren E., Ward F.E., Parham P.; RT "Comparison of class I MHC alleles in humans and apes."; RL Immunol. Rev. 113:147-185(1990). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M30679; AAA87971.1; -; mRNA. DR PIR; I36962; I36962. DR HSSP; P30474; 1A9E. DR SMR; P16210; 25-300. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 362 CHLA class I histocompatibility antigen, FT A-5 alpha chain. FT /FTId=PRO_0000018911. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 362 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 362 AA; 40487 MW; 9B5A674445037056 CRC64; MQVTAPRTVL LLLSAALALT ETWAGSHSMK YFYTAVSRPG RGEPRFISVG YVDDTQFVWF DSDAASPREE PRAPWIEQEG PEYWDRETQI SKTNAQTYRE SLRNLRGYYN QSEAGSHIIQ RMYGCDMGPD GRLLRGYEQY AYDGKDYIAL NQDLSSWTAA DTAAQITQRK WEAARWAEQL RAYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP SSQSTIPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL TA // ID 1A03_GORGO Reviewed; 365 AA. AC P30377; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 48. DE Class I histocompatibility antigen, GOGO-A0401 alpha chain precursor. OS Gorilla gorilla gorilla (Lowland gorilla). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Gorilla. OX NCBI_TaxID=9595; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=92078860; PubMed=1744581; DOI=10.1084/jem.174.6.1491; RA Lawlor D.A., Warren E., Taylor P., Parham P.; RT "Gorilla class I major histocompatibility complex alleles: comparison RT to human and chimpanzee class I."; RL J. Exp. Med. 174:1491-1509(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X60257; CAA42809.1; -; mRNA. DR PIR; JH0536; JH0536. DR HSSP; P10315; 1HSB. DR SMR; P30377; 25-299. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 Class I histocompatibility antigen, GOGO- FT A0401 alpha chain. FT /FTId=PRO_0000018899. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40934 MW; 9207ABBDF9B406C9 CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEE PEYWDGETRN MKARSQTDRV DLGTLRGYYN QSEDGSHTIQ RMYGCDVGSD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAAHEAEQL RAYLEGTCVE WLRRYLENGK ETLQLTDAPK THMTHHPVSD HEAILRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A03_HUMAN Reviewed; 365 AA. AC P04439; O19546; O19756; Q65A82; Q9GJE6; Q9GJE7; Q9GJE8; Q9MYG4; AC Q9TPR8; DT 13-AUG-1987, integrated into UniProtKB/Swiss-Prot. DT 22-AUG-2003, sequence version 2. DT 01-MAY-2007, entry version 70. DE HLA class I histocompatibility antigen, A-3 alpha chain precursor (MHC DE class I antigen A*3). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*0301). RX MEDLINE=84207948; PubMed=6609814; RA Strachan T., Sodoyer R., Damotte M., Jordan B.R.; RT "Complete nucleotide sequence of a functional class I HLA gene, HLA- RT A3: implications for the evolution of HLA genes."; RL EMBO J. 3:887-894(1984). RN [2] RP NUCLEOTIDE SEQUENCE (ALLELE A*0301). RA Ellexson M.E., Hildebrand W.H.; RL Submitted (JUL-1995) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE A*0301). RA Shiina S., Tamiya G., Oka A., Inoko H.; RT "Homo sapiens 2,229,817bp genomic DNA of 6p21.3 HLA class I region."; RL Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE (ALLELE A*0302). RX MEDLINE=85290871; PubMed=2993417; RA Cowan E.P., Jordan B.E., Coligan J.E.; RT "Molecular cloning and DNA sequence analysis of genes encoding RT cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype."; RL J. Immunol. 135:2835-2841(1985). RN [5] RP NUCLEOTIDE SEQUENCE (ALLELE A*0302). RA Bettinotti M.P., Hadzikadic L., Adams S., Marincola F.M.; RT "Complete coding sequence of HLA-A*0302."; RL Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Mayor N.P.; RT "Full length sequence of an HLA-A*0301 intron 2 variant."; RL Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055; RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., RA Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., RA Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S., RA Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J., RA Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P., RA Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., RA Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A., RA Frankland J., French L., Garner P., Garnett J., Ghori M.J., RA Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M., RA Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S., RA Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R., RA Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E., RA Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A., RA Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C., RA Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M., RA Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., RA McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., RA Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R., RA Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W., RA Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M., RA Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L., RA Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J., RA Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B., RA Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L., RA Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W., RA Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A., RA Durbin R., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.; RT "The DNA sequence and analysis of human chromosome 6."; RL Nature 425:805-811(2003). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-341 (ALLELE A*0304). RX MEDLINE=99180630; PubMed=10079303; DOI=10.1007/s002510050506; RA Santos S., Balas A., Garcia-Sanchez F., Lillo R., Merino J.L., RA Vicario J.L.; RT "Complete cDNA coding sequence of a new HLA-A3 subtype (A*0304) with a RT new HLA polymorphism at exon 3."; RL Immunogenetics 49:360-361(1999). RN [9] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*0305). RA Becher M.P., Wu J., Williams T.; RT "Novel human HLA-A alleles identified in potential bone marrow RT donors."; RL Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases. RN [10] RP NUCLEOTIDE SEQUENCE OF 26-298 (ALLELE A*0305). RC TISSUE=Blood; RA Poli F., Frison S., Crespiatico L., Longhi E.; RT "Identification of a HLA-A*03 new variant."; RL Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Dimer of alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-3 are known: A*0301 (A- CC 3.1), A*0302, A*0304 and A*0305. The sequence shown is that of CC A*0301. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X00492; CAA25162.1; ALT_SEQ; Genomic_DNA. DR EMBL; U32184; AAB63980.1; -; mRNA. DR EMBL; BA000025; BAB63400.1; -; Genomic_DNA. DR EMBL; AF217561; AAF28734.1; -; mRNA. DR EMBL; AF015930; AAB66582.1; -; mRNA. DR EMBL; AF190719; AAF03243.1; -; Genomic_DNA. DR EMBL; AF190718; AAF03243.1; JOINED; Genomic_DNA. DR EMBL; AJ401085; CAC06086.1; -; Genomic_DNA. DR EMBL; AJ401086; CAC06087.1; -; Genomic_DNA. DR EMBL; AJ401087; CAC06088.1; -; Genomic_DNA. DR EMBL; AJ748743; CAG38621.1; -; Genomic_DNA. DR EMBL; AL671277; CAI18372.1; -; Genomic_DNA. DR PIR; A02192; HLHUA3. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P04439; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR KEGG; hsa:3105; -. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P04439; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB. DR GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB. DR GO; GO:0006955; P:immune response; NAS:UniProtKB. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-3 alpha chain. FT /FTId=PRO_0000018815. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 176 176 E -> V (in allele A*0302). FT /FTId=VAR_004351. FT VARIANT 180 180 L -> Q (in allele A*0302). FT /FTId=VAR_004352. FT VARIANT 185 185 D -> E (in allele A*0305). FT /FTId=VAR_016604. FT VARIANT 199 199 G -> R (in allele A*0304). FT /FTId=VAR_016605. FT CONFLICT 319 319 G -> A (in Ref. 8). SQ SEQUENCE 365 AA; 40841 MW; DEDFCEC4450E0580 CRC64; MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHEAEQL RAYLDGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL TACKV // ID 1A03_PANTR Reviewed; 365 AA. AC P13748; Q547D5; DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 2. DT 01-MAY-2007, entry version 54. DE CHLA class I histocompatibility antigen, A-108 alpha chain precursor DE (MHC class I antigen Patr-A*0301). GN Name=Patr-A; OS Pan troglodytes (Chimpanzee). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pan. OX NCBI_TaxID=9598; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=89030641; PubMed=2460344; RA Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.; RT "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for RT trans-species mode of evolution."; RL EMBO J. 7:2765-2774(1988). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=22016141; PubMed=12021342; RX DOI=10.1128/JVI.76.12.6093-6103.2002; RA Mizukoshi E., Nascimbeni M., Blaustein J.B., Mihalik K., Rice C.M., RA Liang T.J., Feinstone S.M., Rehermann B.; RT "Molecular and immunological significance of chimpanzee major RT histocompatibility complex haplotypes for hepatitis C virus immune RT response and vaccination studies."; RL J. Virol. 76:6093-6103(2002). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X13113; CAA31505.1; ALT_INIT; mRNA. DR EMBL; AF500288; AAM49754.1; -; mRNA. DR PIR; S03535; S03535. DR HSSP; P10315; 1HSB. DR SMR; P13748; 25-299. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 CHLA class I histocompatibility antigen, FT A-108 alpha chain. FT /FTId=PRO_0000018912. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40823 MW; 48CC757055221FC3 CRC64; MAVMPPRTLL LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDQETRN MKASAQTDRV DLGTLRGYYN QSEDGSHTIQ IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA AMAAQITKRK WEAAHAAEQL RAYLEGRCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAVITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL TACKV // ID 1A04_GORGO Reviewed; 365 AA. AC P30378; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 49. DE Class I histocompatibility antigen, GOGO-A0501 alpha chain precursor. OS Gorilla gorilla gorilla (Lowland gorilla). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Gorilla. OX NCBI_TaxID=9595; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=92078860; PubMed=1744581; DOI=10.1084/jem.174.6.1491; RA Lawlor D.A., Warren E., Taylor P., Parham P.; RT "Gorilla class I major histocompatibility complex alleles: comparison RT to human and chimpanzee class I."; RL J. Exp. Med. 174:1491-1509(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X60256; CAA42808.1; -; mRNA. DR PIR; JH0537; JH0537. DR HSSP; P10315; 1HSB. DR SMR; P30378; 25-302. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 Class I histocompatibility antigen, GOGO- FT A0501 alpha chain. FT /FTId=PRO_0000018900. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40896 MW; 340DAD21F9B3B8AB CRC64; MAVVAPRTLL LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWMEQEE PEYWDRQTQI SKTNAQIELE SLRIALRYYN QSEDGSHTIQ RMYGCDVGSD GRFLRGYQQD AYDGKDYIAS NEDLRSWTAA DMAAEITKRK WEAAHFAEQL RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THTTHQAVSD HEATLKCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A04_PANTR Reviewed; 365 AA. AC P13749; Q7JJU4; DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1990, sequence version 1. DT 01-MAY-2007, entry version 53. DE CHLA class I histocompatibility antigen, A-126 alpha chain precursor DE (MHC class I antigen Patr-A*0401). GN Name=Patr-A; OS Pan troglodytes (Chimpanzee). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pan. OX NCBI_TaxID=9598; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=89030641; PubMed=2460344; RA Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.; RT "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for RT trans-species mode of evolution."; RL EMBO J. 7:2765-2774(1988). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Blood; RX MEDLINE=20322475; PubMed=10866106; DOI=10.1007/s002510050638; RA de Groot N.G., Otting N., Arguello R., Watkins D.I., Doxiadis G.G., RA Madrigal J.A., Bontrop R.E.; RT "Major histocompatibility complex class I diversity in a West African RT chimpanzee population: implications for HIV research."; RL Immunogenetics 51:398-409(2000). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX MEDLINE=22709134; PubMed=12799463; DOI=10.1073/pnas.1230533100; RA Anzai T., Shiina T., Kimura N., Yanagiya K., Kohara S., Shigenari A., RA Yamagata T., Kulski J.K., Naruse T.K., Fujimori Y., Fukuzumi Y., RA Yamazaki M., Tashiro H., Iwamoto C., Umehara Y., Imanishi T., RA Meyer A., Ikeo K., Gojobori T., Bahram S., Inoko H.; RT "Comparative sequencing of human and chimpanzee MHC class I regions RT unveils insertions/deletions as the major path to genomic RT divergence."; RL Proc. Natl. Acad. Sci. U.S.A. 100:7708-7713(2003). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X13114; CAA31506.1; -; mRNA. DR EMBL; AF168401; AAF72782.1; -; mRNA. DR EMBL; BA000041; BAC78189.1; -; Genomic_DNA. DR PIR; S01171; S01171. DR HSSP; P10315; 1HSB. DR SMR; P13749; 25-299. DR KEGG; ptr:450151; -. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 CHLA class I histocompatibility antigen, FT A-126 alpha chain. FT /FTId=PRO_0000018913. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40656 MW; D3C9A810B22A768F CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDEETRS VKASAQTDRV DLGTLRGYYN QSEDGSHTIQ LMFGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAAHAAEQL RAYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD REATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A11_HUMAN Reviewed; 365 AA. AC P13746; O19605; O19606; Q29747; Q29835; Q9BCN0; Q9MYI5; Q9TQE9; AC Q9TQP6; Q9TQP7; DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1990, sequence version 1. DT 01-MAY-2007, entry version 71. DE HLA class I histocompatibility antigen, A-11 alpha chain precursor DE (MHC class I antigen A*11). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*1101 AND A*1102). RX MEDLINE=89030641; PubMed=2460344; RA Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.; RT "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for RT trans-species mode of evolution."; RL EMBO J. 7:2765-2774(1988). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*1101 AND A*1102). RX MEDLINE=94287401; PubMed=8016845; RA Lin L., Tokunaga K., Ishikawa Y., Bannai M., Kashiwase K., Kuwata S., RA Akaza T., Tadokoro K., Shibata Y., Juji T.; RT "Sequence analysis of serological HLA-A11 split antigens, A11.1 and RT A11.2."; RL Tissue Antigens 43:78-82(1994). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-365 (ALLELE A*1101). RX MEDLINE=87192928; PubMed=2437024; DOI=10.1007/BF00404694; RA Cowan E.P., Jelachich M.L., Biddison W.E., Coligan J.E.; RT "DNA sequence of HLA-A11: remarkable homology with HLA-A3 allows RT identification of residues involved in epitopes recognized by RT antibodies and T cells."; RL Immunogenetics 25:241-250(1987). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*1103). RC TISSUE=Blood; RX MEDLINE=20166353; PubMed=10703613; RX DOI=10.1034/j.1399-0039.2000.550113.x; RA Tijssen H.J., Sistermans E.A., van den Beucken M.J.G., Krausa P., RA Joosten I.; RT "Complete sequence analysis of the A*1103 allele."; RL Tissue Antigens 55:68-70(2000). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2) (A*1103). RC TISSUE=Blood; RX MEDLINE=20340071; PubMed=10885562; RX DOI=10.1034/j.1399-0039.2000.550504.x; RA Tijssen H.J., Sistermans E.A., Joosten I.; RT "A unique second donor splice site in the intron 5 sequence of the RT HLA-A*11 alleles results in a class I transcript encoding a molecule RT with an elongated cytoplasmic domain."; RL Tissue Antigens 55:422-428(2000). RN [6] RP NUCLEOTIDE SEQUENCE (ALLELE A*1104). RA Bettinotti M.P.; RL Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*1104). RA Chandanayingyong D., Sirikong M., Luangtrakool K., Srinak D., RA Rungroung E., Bejchandra S.; RT "A11 alleles (A*11O4)."; RL Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases. RN [8] RP NUCLEOTIDE SEQUENCE (ALLELE A*1105). RX MEDLINE=99321035; PubMed=10395112; RX DOI=10.1034/j.1399-0039.1999.530612.x; RA Morrell G., Whalley J., Stewart A., Day S., Lewis L., Makar Y., RA Ross J., Dunn P.P.; RT "Identification of an HLA-A11 serological variant and its RT characterization by sequencing based typing."; RL Tissue Antigens 53:591-594(1999). RN [9] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*1105). RX MEDLINE=20309230; PubMed=10852390; RX DOI=10.1034/j.1399-0039.2000.550412.x; RA Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R., RA Ng J., Hartzman R.J., Hurley C.K.; RT "Seventeen more novel HLA-A locus alleles."; RL Tissue Antigens 55:369-373(2000). RN [10] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*1107). RX MEDLINE=21561663; PubMed=11703829; RX DOI=10.1034/j.1399-0039.2001.580309.x; RA Pyo C.W., Choi H.B., Han H., Hong Y.S., Kim T.G.; RT "Identification of HLA-A*11 variant (A*1107) in the Korean RT population."; RL Tissue Antigens 58:190-192(2001). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P13746-1; Sequence=Displayed; CC Name=2; Synonyms=Long; CC IsoId=P13746-2; Sequence=VSP_008099; CC Note=Only produced by allele A*1103; CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-11 are known: A*1101 (A- CC 11E), A*1102 (A-11K), A*1103, A*1104, A*1105 and A*1107. The CC sequence shown is that of A*1101. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X13111; CAA31503.1; -; mRNA. DR EMBL; X13112; CAA31504.1; -; mRNA. DR EMBL; D16841; BAA04117.1; -; mRNA. DR EMBL; D16842; BAA04118.1; -; mRNA. DR EMBL; M16010; AAA65449.1; -; Genomic_DNA. DR EMBL; M16007; AAA65449.1; JOINED; Genomic_DNA. DR EMBL; M16008; AAA65449.1; JOINED; Genomic_DNA. DR EMBL; M16009; AAA65449.1; JOINED; Genomic_DNA. DR EMBL; Y17224; CAB38056.1; -; mRNA. DR EMBL; Y17224; CAB38057.1; -; mRNA. DR EMBL; X91399; CAA62745.1; -; mRNA. DR EMBL; U50574; AAB60406.1; -; mRNA. DR EMBL; AF030910; AAB87052.1; -; Genomic_DNA. DR EMBL; AF030909; AAB87052.1; JOINED; Genomic_DNA. DR EMBL; AF030908; AAB87051.1; -; Genomic_DNA. DR EMBL; AF030907; AAB87051.1; JOINED; Genomic_DNA. DR EMBL; AJ306733; CAC37336.1; -; Genomic_DNA. DR EMBL; AF147455; AAD33991.1; -; Genomic_DNA. DR EMBL; AF147454; AAD33991.1; JOINED; Genomic_DNA. DR EMBL; AF165065; AAF25781.1; -; mRNA. DR PIR; I83063; I83063. DR PIR; S03536; A47636. DR UniGene; Hs.181244; -. DR PDB; 1Q94; X-ray; A/D=25-299. DR PDB; 1QVO; X-ray; A/D=25-299. DR PDB; 1X7Q; X-ray; A=25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P13746; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB. DR GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB. DR GO; GO:0006955; P:immune response; NAS:UniProtKB. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW 3D-structure; Alternative splicing; Glycoprotein; KW Host-virus interaction; Immune response; Membrane; MHC I; KW Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-11 alpha chain. FT /FTId=PRO_0000018816. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VAR_SEQ 337 337 S -> SGGEGVK (in isoform 2). FT /FTId=VSP_008099. FT VARIANT 43 43 E -> K (in allele A*1102). FT /FTId=VAR_004353. FT VARIANT 133 133 F -> L (in allele A*1107). FT /FTId=VAR_016731. FT VARIANT 168 168 K -> E (in allele A*1105). FT /FTId=VAR_016732. FT VARIANT 175 175 H -> R (in allele A*1103). FT /FTId=VAR_016733. FT VARIANT 176 176 A -> E (in allele A*1103). FT /FTId=VAR_016734. FT VARIANT 187 187 R -> T (in allele A*1104). FT /FTId=VAR_016735. FT VARIANT 345 345 T -> S (in allele A*1105). FT /FTId=VAR_016736. FT STRAND 27 36 FT STRAND 41 43 FT STRAND 45 52 FT STRAND 55 61 FT STRAND 64 66 FT HELIX 74 76 FT HELIX 81 108 FT STRAND 113 115 FT STRAND 118 127 FT STRAND 133 142 FT STRAND 145 150 FT STRAND 157 159 FT HELIX 162 173 FT HELIX 176 185 FT HELIX 187 198 FT HELIX 200 203 FT STRAND 210 217 FT STRAND 219 235 FT STRAND 238 243 FT STRAND 252 254 FT STRAND 261 263 FT STRAND 265 274 FT HELIX 278 280 FT STRAND 281 286 FT STRAND 294 297 SQ SEQUENCE 365 AA; 40937 MW; FE449CE2D4BF6CC5 CRC64; MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAAHAAEQQ RAYLEGRCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL TACKV // ID 1A23_HUMAN Reviewed; 365 AA. AC P30447; Q9TQF1; Q9TQF8; Q9TQG5; Q9TQM6; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 59. DE HLA class I histocompatibility antigen, A-23 alpha chain precursor DE (MHC class I antigen A*23) (A-9). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*2301). RX MEDLINE=92104637; PubMed=1729171; DOI=10.1007/BF00216625; RA Little A.-M., Madrigal J.A., Parham P.; RT "Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3."; RL Immunogenetics 35:41-45(1992). RN [2] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*2302 AND A*2303). RX MEDLINE=20309230; PubMed=10852390; RX DOI=10.1034/j.1399-0039.2000.550412.x; RA Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R., RA Ng J., Hartzman R.J., Hurley C.K.; RT "Seventeen more novel HLA-A locus alleles."; RL Tissue Antigens 55:369-373(2000). RN [3] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*2304 AND A*2305). RX MEDLINE=21068830; PubMed=11169246; RX DOI=10.1034/j.1399-0039.2000.560610.x; RA Steiner N.K., Edson S.M., Mitton W., Ng J., Hartzman R.J., RA Hurley C.K.; RT "Seven novel HLA-A alleles carry previously observed polymorphisms."; RL Tissue Antigens 56:551-552(2000). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-23 are known: A*2301, CC A*2302, A*2303, A*2304 and A*2305. The sequence shown is that of CC A*2301. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M64742; AAA03662.1; -; Unassigned_RNA. DR EMBL; AF137080; AAD33736.1; -; Genomic_DNA. DR EMBL; AF137079; AAD33736.1; JOINED; Genomic_DNA. DR EMBL; AF102572; AAD28171.1; -; Genomic_DNA. DR EMBL; AF102571; AAD28171.1; JOINED; Genomic_DNA. DR EMBL; AF135549; AAD22272.1; -; Genomic_DNA. DR EMBL; AF135548; AAD22272.1; JOINED; Genomic_DNA. DR EMBL; AF140860; AAD31878.1; -; Genomic_DNA. DR EMBL; AF140859; AAD31878.1; JOINED; Genomic_DNA. DR HSSP; Q29961; 1HSA. DR SMR; P30447; 25-302. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P30447; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-23 alpha chain. FT /FTId=PRO_0000018817. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 31 31 Y -> C (in allele A*2305). FT /FTId=VAR_016606. FT VARIANT 151 151 K -> N (in allele A*2303). FT /FTId=VAR_016607. FT VARIANT 180 180 L -> W (in allele A*2302). FT /FTId=VAR_016608. FT VARIANT 190 191 DG -> EW (in allele A*2304). FT /FTId=VAR_016609. SQ SEQUENCE 365 AA; 40733 MW; C372DE503BF393D0 CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDEETGK VKAHSQTDRE NLRIALRYYN QSEAGSHTLQ MMFGCDVGSD GRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQITQRK WEAARVAEQL RAYLEGTCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP SSQPTVHIVG IIAGLVLLGA VITGAVVAAV MWRRNSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A24_HUMAN Reviewed; 365 AA. AC P05534; P30448; P30449; Q29908; Q29909; Q29910; Q95355; DT 01-NOV-1988, integrated into UniProtKB/Swiss-Prot. DT 27-JUN-2003, sequence version 2. DT 01-MAY-2007, entry version 81. DE HLA class I histocompatibility antigen, A-24 alpha chain precursor DE (MHC class I antigen A*24) (Aw-24) (A-9). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*2401). RX MEDLINE=85206128; PubMed=2987115; RA N'Guyen C., Sodoyer R., Trucy J., Strachan T., Jordan B.R.; RT "The HLA-AW24 gene: sequence, surroundings and comparison with the RT HLA-A2 and HLA-A3 genes."; RL Immunogenetics 21:479-489(1985). RN [2] RP SEQUENCE REVISION. RA Jordan B.R.; RL Submitted (JUL-1988) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELES A*2402 AND A*2403). RX MEDLINE=92104637; PubMed=1729171; DOI=10.1007/BF00216625; RA Little A.-M., Madrigal J.A., Parham P.; RT "Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3."; RL Immunogenetics 35:41-45(1992). RN [4] RP NUCLEOTIDE SEQUENCE (ALLELE A*2402). RX MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0; RA Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J., RA Williams R.C., Luz R., Petzl-Erler M.L., Parham P.; RT "Unusual HLA-B alleles in two tribes of Brazilian Indians."; RL Nature 357:326-329(1992). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*2402). RX MEDLINE=98007772; PubMed=9349616; RA Laforet M., Froelich N., Parissiadis A., Bausinger H., Pfeiffer B., RA Tongio M.M.; RT "An intronic mutation responsible for a low level of expression of an RT HLA-A*24 allele."; RL Tissue Antigens 50:340-346(1997). RN [6] RP NUCLEOTIDE SEQUENCE (ALLELE A*2408). RC TISSUE=Blood; RA Kashiwase K., Tokunaga K., Ishikawa Y., Qiu L., Furuya M., RA Sawanaka K., Akaza T., Tadokoro K., Juji T.; RT "Sequence analysis of a serological subtype, HLA-A9HH, observed in RT Japanese and the confirmatory sequence of A*2408."; RL MHC 3:9-14(1996). RN [7] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*2410). RC TISSUE=Blood; RX MEDLINE=97161044; PubMed=9008316; RA Gao X., Matheson B.; RT "A novel HLA-A*24 (A*2410) identified in a Javanese population."; RL Tissue Antigens 48:711-713(1996). RN [8] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELES A*2406; A*2413 RP AND A*2414). RC TISSUE=Blood; RX MEDLINE=97417771; PubMed=9271829; RA Gao X., Lester S., Matheson B., Boettcher B., McCluskey J.; RT "Three newly identified A*24 alleles: A*2406, A*2413 and A*2414."; RL Tissue Antigens 50:192-196(1997). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-24 are known: A*2401, CC A*2402, A*2403, A*2406, A*2408 (A9HH), A*2410 (A*24JV), A*2413 CC (A*24YM) and A*2414 (A*24SA). Allele A*2402 is represented in all CC major racial groups. Allele A*2406 and allele A*2413 are found in CC the Australian Aborigenal population. Allele A*2414 is found in CC individuals of South American descent. The sequence shown is that CC of A*2402. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M15497; AAA59611.1; -; Genomic_DNA. DR EMBL; M64740; AAA59600.1; -; mRNA. DR EMBL; M64741; AAA59601.1; -; Genomic_DNA. DR EMBL; Z72422; CAA96532.1; -; Genomic_DNA. DR EMBL; D83516; BAA11936.1; -; mRNA. DR EMBL; U37111; AAA83264.1; -; Genomic_DNA. DR EMBL; U37110; AAA83264.1; JOINED; Genomic_DNA. DR EMBL; U37113; AAA83265.1; -; Genomic_DNA. DR EMBL; U37112; AAA83265.1; JOINED; Genomic_DNA. DR EMBL; U37115; AAB40048.1; -; Genomic_DNA. DR EMBL; U37114; AAB40048.1; JOINED; Genomic_DNA. DR EMBL; U19733; AAB60651.1; -; Genomic_DNA. DR EMBL; U18987; AAB60651.1; JOINED; Genomic_DNA. DR PIR; I54416; I54416. DR UniGene; Hs.181244; -. DR PDB; 2BCK; X-ray; A/D=25-302. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P05534; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW 3D-structure; Glycoprotein; Host-virus interaction; Immune response; KW Membrane; MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-24 alpha chain. FT /FTId=PRO_0000018818. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 5 5 A -> G (in allele A*2401). FT /FTId=VAR_004354. FT VARIANT 27 27 H -> Q (in allele A*2408). FT /FTId=VAR_004355. FT VARIANT 86 86 E -> G (in allele A*2408). FT /FTId=VAR_004356. FT VARIANT 89 89 G -> R (in allele A*2408). FT /FTId=VAR_004357. FT VARIANT 119 119 L -> V (in allele A*2414). FT /FTId=VAR_015765. FT VARIANT 121 121 M -> R (in allele A*2414). FT /FTId=VAR_015766. FT VARIANT 123 123 F -> Y (in allele A*2414). FT /FTId=VAR_015767. FT VARIANT 131 131 G -> W (in allele A*2414). FT /FTId=VAR_015768. FT VARIANT 180 180 Q -> L (in allele A*2413). FT /FTId=VAR_015769. FT VARIANT 180 180 Q -> W (in allele A*2406; requires 2 FT nucleotide substitutions). FT /FTId=VAR_004358. FT VARIANT 187 187 T -> R (in allele A*2410). FT /FTId=VAR_015770. FT VARIANT 190 191 DG -> EW (in allele A*2403 and allele FT A*2410). FT /FTId=VAR_004359. FT VARIANT 206 206 T -> A (in allele A*2401). FT /FTId=VAR_004360. FT STRAND 27 36 FT STRAND 41 43 FT STRAND 45 52 FT STRAND 55 61 FT STRAND 64 66 FT HELIX 74 76 FT HELIX 81 108 FT STRAND 118 127 FT STRAND 133 142 FT STRAND 145 150 FT STRAND 157 159 FT HELIX 162 173 FT HELIX 176 185 FT HELIX 187 197 FT HELIX 200 203 FT STRAND 212 217 FT STRAND 219 235 FT STRAND 238 243 FT HELIX 249 251 FT STRAND 252 254 FT STRAND 261 263 FT STRAND 265 274 FT HELIX 278 280 FT STRAND 281 286 FT STRAND 290 292 FT STRAND 294 296 FT STRAND 298 302 SQ SEQUENCE 365 AA; 40689 MW; D33684D126F98EC3 CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFSTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDEETGK VKAHSQTDRE NLRIALRYYN QSEAGSHTLQ MMFGCDVGSD GRFLRGYHQY AYDGKDYIAL KEDLRSWTAA DMAAQITKRK WEAAHVAEQQ RAYLEGTCVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP SSQPTVPIVG IIAGLVLLGA VITGAVVAAV MWRRNSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A25_HUMAN Reviewed; 365 AA. AC P18462; Q95362; Q9TQE8; Q9TQG0; Q9UQU3; DT 01-NOV-1990, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1990, sequence version 1. DT 01-MAY-2007, entry version 70. DE HLA class I histocompatibility antigen, A-25 alpha chain precursor DE (MHC class I antigen A*25) (A-10). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*2501). RX MEDLINE=90207291; PubMed=2320591; RA Ennis P.D., Zemmour J., Salter R.D., Parham P.; RT "Rapid cloning of HLA-A,B cDNA by using the polymerase chain reaction: RT frequency and nature of errors produced in amplification."; RL Proc. Natl. Acad. Sci. U.S.A. 87:2833-2837(1990). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE A*2501). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*2502). RC TISSUE=Hematopoietic; RX MEDLINE=97045042; PubMed=8881046; DOI=10.1007/s002510050175; RA Krausa P., Young D.M., Gotch F.; RT "Identification of a new HLA-A allele (A*2502) by PCR-SSP."; RL Immunogenetics 45:84-85(1996). RN [4] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*2502). RA Guttridge M.G.; RT "Sequence confirmation of HLA-A*2502."; RL Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*2503). RX MEDLINE=20309230; PubMed=10852390; RX DOI=10.1034/j.1399-0039.2000.550412.x; RA Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R., RA Ng J., Hartzman R.J., Hurley C.K.; RT "Seventeen more novel HLA-A locus alleles."; RL Tissue Antigens 55:369-373(2000). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-25 are known: A*2501 CC A*2502 and A*2503. The sequence shown is that of A*2501. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M32321; AAA36234.1; -; mRNA. DR EMBL; BC008611; AAH08611.1; -; mRNA. DR EMBL; X97802; CAA66389.1; -; mRNA. DR EMBL; AJ238524; CAB41888.1; -; Genomic_DNA. DR EMBL; AF137076; AAD33737.1; -; Genomic_DNA. DR EMBL; AF137075; AAD33737.1; JOINED; Genomic_DNA. DR EMBL; AF148898; AAD34010.1; -; Genomic_DNA. DR EMBL; AF148897; AAD34010.1; JOINED; Genomic_DNA. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P18462; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P18462; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-25 alpha chain. FT /FTId=PRO_0000018819. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 33 33 Y -> F (in allele A*2503). FT /FTId=VAR_016737. FT VARIANT 94 94 H -> Q (in allele A*2502). FT /FTId=VAR_004361. SQ SEQUENCE 365 AA; 41218 MW; 00F71BD2F97C3620 CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAHSQTDRE SLRIALRYYN QSEDGSHTIQ RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A26_HUMAN Reviewed; 365 AA. AC P30450; O02963; O78073; P79563; Q30208; Q31623; Q95377; Q9BD15; AC Q9BD19; Q9MW42; Q9TQK5; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 2. DT 01-MAY-2007, entry version 67. DE HLA class I histocompatibility antigen, A-26 alpha chain precursor DE (MHC class I antigen A*26). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELES A*2601 AND A*2602). RX MEDLINE=93235211; PubMed=8475492; RA Madrigal J.A., Hildebrand W.H., Belich M.P., Benjamin R.J., RA Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., RA du Toit E.D., Parham P.; RT "Structural diversity in the HLA-A10 family of alleles: correlations RT with serology."; RL Tissue Antigens 41:72-80(1993). RN [2] RP NUCLEOTIDE SEQUENCE (ALLELE A*2601). RX MEDLINE=90256559; PubMed=1692821; DOI=10.1016/0198-8859(90)90047-S; RA Zinzsner H., Masset M., Bourge J.-F., Colombani J., Cohen D., RA Degos L., Paul P.; RT "Nucleotide sequence of the HLA-A26 class I gene: identification of RT specific residues and molecular mapping of public HLA class I RT epitopes."; RL Hum. Immunol. 27:155-166(1990). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*2601; A*2602; A*2603 AND RP A*2604). RC TISSUE=Blood; RX MEDLINE=94299439; PubMed=8026990; DOI=10.1016/0198-8859(94)90263-1; RA Ishikawa Y., Tokunaga K., Lin L., Imanishi T., Saitou S., RA Kashiwase K., Akaza T., Tadokoro K., Juji T.; RT "Sequences of four splits of HLA-A10 group. Implications for serologic RT cross-reactivities and their evolution."; RL Hum. Immunol. 39:220-224(1994). RN [4] RP NUCLEOTIDE SEQUENCE (ALLELE A*2601). RC TISSUE=Lymphocyte; RA Miyashita H., Fujiyoshi T., Yashiki S., Kuwayama M., Fujiyama C., RA Sonoda S.; RL Submitted (JUL-1994) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*2603). RC TISSUE=Lymphocyte; RX MEDLINE=96435465; PubMed=8838351; RA Miyashita H., Fujiyoshi T., Yashiki S., Kuwayama M., Fujiyama C., RA Sonoda S.; RT "Cloning of HLA-A26 cDNA from Japanese donors possessing 'ATL- RT associated HLA haplotypes'."; RL Tissue Antigens 46:398-400(1995). RN [6] RP NUCLEOTIDE SEQUENCE (ALLELE A*2605). RC TISSUE=Blood; RA Maruya E., Ishikawa Y., Lin L., Tokunaga K., Kimura A., Saitou S., RA Nita H., Juji T., Saji H.; RT "A novel A26 sequence found in Japanese, and identification of four RT major HLA-A26 subtypes."; RL Submitted (APR-1995) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*2607). RX MEDLINE=96387673; PubMed=8795143; RA Arnett K.L., Moses J.H., Williams F., Marsh S.G.E., Bodmer J.G., RA Parham P., Middleton D.; RT "HLA-A *2607: sequence of a novel A*26 subtype predicted by DNA typing RT which shares the MA2.1 epitope with A*02, B*57 and B*58."; RL Tissue Antigens 47:422-425(1996). RN [8] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*2608). RX MEDLINE=97051455; PubMed=8896181; RA Szmania S., Baxter-Lowe L.A.; RT "Nucleotide sequence for HLA-A*2608 which encodes glutamine at codon RT 156."; RL Tissue Antigens 48:210-212(1996). RN [9] RP NUCLEOTIDE SEQUENCE (ALLELE A*2608). RA Ellexson M.E., Hildebrand W.H.; RL Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases. RN [10] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*2612). RX MEDLINE=20548605; PubMed=11098929; RX DOI=10.1034/j.1399-0039.2000.560401.x; RA Ellis J.M., Mack S.J., Leke R.F.G., Quakyi I., Johnson A.H., RA Hurley C.K.; RT "Diversity is demonstrated in class I HLA-A and HLA-B alleles in RT Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA- RT B*1403, *4016, *4703."; RL Tissue Antigens 56:291-302(2000). RN [11] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*2612). RX MEDLINE=21160440; PubMed=11260503; RX DOI=10.1034/j.1399-0039.2001.057002095.x; RA Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N., RA Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A., RA Confer D.L., Hildebrand W.H.; RT "Non-conservative substitutions distinguish previously uncharacterized RT HLA-A molecules."; RL Tissue Antigens 57:95-102(2001). RN [12] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*2615). RA Voorter C.E., Gervais T., van den Berg-Loonene E.M.; RT "New HLA-A alleles detected by sequence-based typing."; RL Submitted (NOV-2000) to the EMBL/GenBank/DDBJ databases. RN [13] RP NUCLEOTIDE SEQUENCE OF 26-298 (ALLELE A*2607). RA Moine A.; RT "A new variant form of a HLA A*2607 allele."; RL Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases. RN [14] RP NUCLEOTIDE SEQUENCE [MRNA] OF 27-365 (ALLELE A*2601). RX MEDLINE=89122144; PubMed=2914713; RA Cianetti L., Testa U., Scotto L., la Valle R., Simeone A., Boccoli G., RA Giannella G., Peschle C., Boncinelli E.; RT "Three new class I HLA alleles: structure of mRNAs and alternative RT mechanisms of processing."; RL Immunogenetics 29:80-91(1989). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- INTERACTION: CC P16188:HLA-A; NbExp=1; IntAct=EBI-1042870, EBI-1044129; CC Q53QP2:UGCGL1; NbExp=1; IntAct=EBI-1042870, EBI-1056389; CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-26 are known: A*2601, CC A*2602, A*2603, A*2604 (A-10SA), A*2605, A*2607, A*2608, A*2612 CC and A*2615. The sequence shown is that of A*2601. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; U03697; AAA03720.1; -; mRNA. DR EMBL; M98453; AAA35991.1; -; mRNA. DR EMBL; D14350; BAA03279.1; -; mRNA. DR EMBL; D14351; BAA03280.1; -; mRNA. DR EMBL; D14354; BAA03282.1; -; mRNA. DR EMBL; D16843; BAA04119.1; -; mRNA. DR EMBL; D32130; BAA06856.1; -; mRNA. DR EMBL; D32131; BAA06857.1; -; mRNA. DR EMBL; D32129; BAA06855.1; -; mRNA. DR EMBL; D50068; BAA08783.1; -; mRNA. DR EMBL; L48341; AAF25960.1; -; Genomic_DNA. DR EMBL; U52429; AAB08574.1; -; mRNA. DR EMBL; U45480; AAB38491.1; -; mRNA. DR EMBL; AF065487; AAC17438.1; -; Genomic_DNA. DR EMBL; AF065486; AAC17438.1; JOINED; Genomic_DNA. DR EMBL; AF042187; AAD02210.1; -; Genomic_DNA. DR EMBL; AF042186; AAD02210.1; JOINED; Genomic_DNA. DR EMBL; AJ291695; CAC27239.1; -; Genomic_DNA. DR EMBL; AJ291696; CAC27239.1; JOINED; Genomic_DNA. DR EMBL; AJ290394; CAC27416.2; -; mRNA. DR EMBL; M24095; AAA59655.1; -; mRNA. DR PIR; I38436; I38436. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P30450; 25-299. DR IntAct; P30450; -. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P30450; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR GO; GO:0005515; F:protein binding; IPI:IntAct. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-26 alpha chain. FT /FTId=PRO_0000018820. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 60 60 F -> L (in allele A*2615). FT /FTId=VAR_016341. FT VARIANT 86 87 RN -> GE (in allele A*2607). FT /FTId=VAR_016342. FT VARIANT 90 90 N -> K (in allele A*2607). FT /FTId=VAR_016343. FT VARIANT 98 101 DRAN -> HRVD (in allele A*2603). FT /FTId=VAR_004362. FT VARIANT 100 100 A -> E (in allele A*2605). FT /FTId=VAR_016344. FT VARIANT 140 140 D -> N (in allele A*2602). FT /FTId=VAR_004364. FT VARIANT 176 176 E -> V (in allele A*2612). FT /FTId=VAR_016345. FT VARIANT 180 180 W -> Q (in allele A*2608; requires 2 FT nucleotide substitutions). FT /FTId=VAR_016346. FT VARIANT 187 187 R -> L (in allele A*2604). FT /FTId=VAR_004363. FT VARIANT 306 306 I -> V (in dbSNP:rs1136949). FT /FTId=VAR_014603. FT CONFLICT 153 153 D -> H (in Ref. 14). FT CONFLICT 160 160 A -> G (in Ref. 14). SQ SEQUENCE 365 AA; 41062 MW; 44B54DD363B46EDA CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A29_HUMAN Reviewed; 365 AA. AC P30512; O02955; O19687; O98011; P30451; P79562; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 15-JUL-1998, sequence version 2. DT 01-MAY-2007, entry version 67. DE HLA class I histocompatibility antigen, A-29 alpha chain precursor DE (MHC class I antigen A*29) (Aw-19). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*2901). RX MEDLINE=89065816; PubMed=2461903; RA Trapani J.A., Mizuno S., Kang S.H., Yang S.Y., Dupont B.; RT "Molecular mapping of a new public HLA class I epitope shared by all RT HLA-B and HLA-C antigens and defined by a monoclonal antibody."; RL Immunogenetics 29:25-32(1989). RN [2] RP SEQUENCE REVISION TO 345. RA Yang S.Y.; RL Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE (ALLELE A*2901). RA Szmania S., Baxter-Lowe L.A.; RL Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*2902). RX MEDLINE=92145462; PubMed=1782566; RA Tabary T., Prochnicka-Chalufour A., Cornillet P., Lehoang P., RA Betuel H., Cohen H.M.; RT "HLA-A29 sub-types and 'Birdshot' choroido-retinopathy susceptibility: RT a possible 'resistance motif' in the HLA-A29.1 molecule."; RL C. R. Acad. Sci. III, Sci. Vie 313:599-605(1991). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ALLELE A*2903). RX MEDLINE=98119601; PubMed=9459513; RA Prokupek B., Dunn P., Ross J., Jordan F., Holman R., Madrigal J.A., RA Little A.-M.; RT "HLA-A*2903 expresses an epitope shared with HLA-A*8001."; RL Tissue Antigens 51:115-118(1998). RN [6] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*2904). RX MEDLINE=21160440; PubMed=11260503; RX DOI=10.1034/j.1399-0039.2001.057002095.x; RA Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N., RA Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A., RA Confer D.L., Hildebrand W.H.; RT "Non-conservative substitutions distinguish previously uncharacterized RT HLA-A molecules."; RL Tissue Antigens 57:95-102(2001). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-29 are known: A*2901 CC (A29.1), A*2902 (A29.2), A*2903 and A*2904. The sequence shown is CC that of A*2901. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M23739; AAB47873.1; -; mRNA. DR EMBL; U83415; AAB53373.1; -; mRNA. DR EMBL; X60108; CAA42702.1; -; mRNA. DR EMBL; AJ000661; CAA04209.1; -; mRNA. DR EMBL; Y09218; CAA70419.1; -; Genomic_DNA. DR EMBL; AF042189; AAD02224.1; -; Genomic_DNA. DR EMBL; AF042188; AAD02224.1; JOINED; Genomic_DNA. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P30512; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P30512; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-29 alpha chain. FT /FTId=PRO_0000018821. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 90 90 N -> H (in allele A*2904). FT /FTId=VAR_016347. FT VARIANT 126 126 H -> D (in allele A*2902, allele A*2903 FT and allele A*2904). FT /FTId=VAR_004365. FT VARIANT 190 191 EW -> DG (in allele A*2903). FT /FTId=VAR_010372. SQ SEQUENCE 365 AA; 40863 MW; 56E4B9039B3C783C CRC64; MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFTTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDLQTRN VKAQSQTDRA NLGTLRGYYN QSEAGSHTIQ MMYGCHVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A30_HUMAN Reviewed; 365 AA. AC P16188; O19598; O62921; P30452; Q9UIP7; DT 01-APR-1990, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1996, sequence version 2. DT 01-MAY-2007, entry version 68. DE HLA class I histocompatibility antigen, A-30 alpha chain precursor DE (MHC class I antigen A*30). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*3001). RX MEDLINE=90038496; PubMed=2478623; RA Kato K., Trapani J.A., Allopenna J., Dupont B., Yang S.Y.; RT "Molecular analysis of the serologically defined HLA-Aw19 antigens. A RT genetically distinct family of HLA-A antigens comprising A29, A31, RT A32, and Aw33, but probably not A30."; RL J. Immunol. 143:3371-3378(1989). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*3001). RX MEDLINE=95176329; PubMed=7871528; RA Olerup O., Daniels T.J., Baxter-Lowe L.; RT "Correct sequence of the A*3001 allele obtained by PCR-SSP typing and RT automated nucleotide sequencing."; RL Tissue Antigens 44:265-267(1994). RN [3] RP NUCLEOTIDE SEQUENCE (ALLELE A*3002). RX MEDLINE=93056508; PubMed=1431115; RA Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J., RA Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., RA Martell R.W., du Toit E.D., Parham P.; RT "Distinctive HLA-A,B antigens of black populations formed by RT interallelic conversion."; RL J. Immunol. 149:3411-3415(1992). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-279 (ALLELE A*3003). RX MEDLINE=93209813; PubMed=8458735; DOI=10.1016/0198-8859(93)90004-K; RA Choo S.Y., Starling G.C., Anasetti C., Hansen J.A.; RT "Selection of an unrelated donor for marrow transplantation RT facilitated by the molecular characterization of a novel HLA-A RT allele."; RL Hum. Immunol. 36:20-26(1993). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*3004). RX MEDLINE=96058597; PubMed=8522453; DOI=10.1016/0198-8859(95)00046-7; RA Krausa P., Carcassi C., Orru S., Bodmer J.G., Browning M.J., Contu L.; RT "Defining the allelic variants of HLA-A30 in the Sardinian population RT using amplification refractory mutation system -- polymerase chain RT reaction."; RL Hum. Immunol. 44:35-42(1995). RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 26-206 (ALLELE A*3004). RX MEDLINE=96435464; PubMed=8838350; RA Lienert K., Russ G., Bennett G., Gao X., McCluskey J.; RT "HLA-A*3004: a new A30 allele identified in an Australian Caucasoid RT population."; RL Tissue Antigens 46:394-397(1995). RN [7] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 28-205 (ALLELE A*3004). RX MEDLINE=96124443; PubMed=8560452; RA Blasczyk R., Wehling J., Paessler M., Hahn U., Huhn D., Salama A.; RT "A novel HLA-A30 allele (A*3004) identified by single-strand RT conformation polymorphism analysis and confirmed by solid-phase RT sequencing."; RL Tissue Antigens 46:322-326(1995). RN [8] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3006). RX MEDLINE=20548605; PubMed=11098929; RX DOI=10.1034/j.1399-0039.2000.560401.x; RA Ellis J.M., Mack S.J., Leke R.F.G., Quakyi I., Johnson A.H., RA Hurley C.K.; RT "Diversity is demonstrated in class I HLA-A and HLA-B alleles in RT Cameroon, Africa: description of HLA-A*03012, *2612, *3006 and HLA- RT B*1403, *4016, *4703."; RL Tissue Antigens 56:291-302(2000). RN [9] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3007). RX MEDLINE=20309230; PubMed=10852390; RX DOI=10.1034/j.1399-0039.2000.550412.x; RA Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R., RA Ng J., Hartzman R.J., Hurley C.K.; RT "Seventeen more novel HLA-A locus alleles."; RL Tissue Antigens 55:369-373(2000). RN [10] RP NUCLEOTIDE SEQUENCE (ALLELE A*3008). RX MEDLINE=21108617; PubMed=11169261; RX DOI=10.1034/j.1399-0039.2001.057001070.x; RA Cox S.T., Mcwhinnie A.J., Koester R.P., Heine U., Holman R., RA Madrigal A.J., Little A.-M.; RT "Further diversity at HLA-A and -B loci identified in Afro-Caribbean RT potential bone marrow donors."; RL Tissue Antigens 57:70-72(2001). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- INTERACTION: CC P30450:HLA-A; NbExp=1; IntAct=EBI-1044129, EBI-1042870; CC P30457:HLA-A; NbExp=1; IntAct=EBI-1044129, EBI-1049899; CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-30 are known: A*3001 CC (A30.3), A*3002, A*3003, A*3004 (A30W7), A*3006, A*3007 and CC A*3008. The sequence shown is that of A*3001. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M30576; AAA59612.1; -; Genomic_DNA. DR EMBL; U07234; AAA70162.1; -; mRNA. DR EMBL; X61702; CAA43871.1; -; mRNA. DR EMBL; M93657; AAA58650.1; -; Genomic_DNA. DR EMBL; Z34921; CAA84401.1; -; Genomic_DNA. DR EMBL; U19734; AAB53658.1; -; Genomic_DNA. DR EMBL; U18988; AAB53658.1; JOINED; Genomic_DNA. DR EMBL; U24261; AAB50434.1; -; mRNA. DR EMBL; X83770; CAA58723.1; -; Genomic_DNA. DR EMBL; X83771; CAA58724.1; -; Genomic_DNA. DR EMBL; AF028714; AAC14191.1; -; Genomic_DNA. DR EMBL; AF028713; AAC14191.1; JOINED; Genomic_DNA. DR EMBL; AF065643; AAC18600.1; -; Genomic_DNA. DR EMBL; AF065642; AAC18600.1; JOINED; Genomic_DNA. DR EMBL; AJ249308; CAB57306.1; -; Genomic_DNA. DR EMBL; AJ249309; CAB57306.1; JOINED; Genomic_DNA. DR EMBL; AJ249310; CAB57306.1; JOINED; Genomic_DNA. DR EMBL; AJ249311; CAB57306.1; JOINED; Genomic_DNA. DR EMBL; AJ249312; CAB57306.1; JOINED; Genomic_DNA. DR EMBL; AJ249313; CAB57306.1; JOINED; Genomic_DNA. DR EMBL; AJ249314; CAB57306.1; JOINED; Genomic_DNA. DR EMBL; AJ249315; CAB57306.1; JOINED; Genomic_DNA. DR PIR; I38519; I38519. DR PIR; I56039; I56039. DR HSSP; P10315; 1HSB. DR SMR; P16188; 25-299. DR IntAct; P16188; -. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P16188; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB. DR GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB. DR GO; GO:0005515; F:protein binding; IPI:IntAct. DR GO; GO:0006955; P:immune response; NAS:UniProtKB. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-30 alpha chain. FT /FTId=PRO_0000018822. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 21 21 H -> Q (in allele A*3002, allele A*3004 FT and allele A*3008). FT /FTId=VAR_004366. FT VARIANT 33 33 S -> Y (in allele A*3008). FT /FTId=VAR_010284. FT VARIANT 55 55 T -> A (in allele A*3006). FT /FTId=VAR_016653. FT VARIANT 80 80 R -> G (in allele A*3003). FT /FTId=VAR_004367. FT VARIANT 86 86 Q -> E (in allele A*3007). FT /FTId=VAR_016738. FT VARIANT 89 90 RN -> GK (in allele A*3007). FT /FTId=VAR_016739. FT VARIANT 94 94 Q -> H (in allele A*3002, allele A*3003, FT allele A*3004, allele A*3006 and allele FT A*3007). FT /FTId=VAR_004368. FT VARIANT 100 101 VD -> EN (in allele A*3002, allele FT A*3003, allele A*3004, allele A*3006 and FT allele A*3007). FT /FTId=VAR_004369. FT VARIANT 175 176 RW -> HV (in allele A*3004 and allele FT A*3006). FT /FTId=VAR_004370. FT VARIANT 176 176 W -> R (in allele A*3002, allele A*3003 FT and allele A*3007). FT /FTId=VAR_004371. FT VARIANT 180 180 L -> W (in allele A*3004 and allele FT A*3006). FT /FTId=VAR_004372. FT CONFLICT 33 33 S -> F (in Ref. 1). SQ SEQUENCE 365 AA; 40905 MW; 521166D95FB1DC28 CRC64; MAVMAPRTLL LLLSGALALT HTWAGSHSMR YFSTSVSRPG SGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQER PEYWDQETRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ IMYGCDVGSD GRFLRGYEQH AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARWAEQL RAYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL TACKV // ID 1A31_HUMAN Reviewed; 365 AA. AC P16189; O62924; O98009; O98137; Q8MHM1; Q9TPQ3; Q9TQ24; Q9UQU6; AC Q9UQU7; DT 01-APR-1990, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 2. DT 01-MAY-2007, entry version 67. DE HLA class I histocompatibility antigen, A-31 alpha chain precursor DE (MHC class I antigen A*31). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*3101). RX MEDLINE=90038496; PubMed=2478623; RA Kato K., Trapani J.A., Allopenna J., Dupont B., Yang S.Y.; RT "Molecular analysis of the serologically defined HLA-Aw19 antigens. A RT genetically distinct family of HLA-A antigens comprising A29, A31, RT A32, and Aw33, but probably not A30."; RL J. Immunol. 143:3371-3378(1989). RN [2] RP NUCLEOTIDE SEQUENCE (ALLELE A*3101). RX MEDLINE=92269955; PubMed=1317015; DOI=10.1038/357326a0; RA Belich M.P., Madrigal J.A., Hildebrand W.H., Zemmour J., RA Williams R.C., Luz R., Petzl-Erler M.L., Parham P.; RT "Unusual HLA-B alleles in two tribes of Brazilian Indians."; RL Nature 357:326-329(1992). RN [3] RP NUCLEOTIDE SEQUENCE (ALLELE A*3101). RX MEDLINE=96387675; PubMed=8795145; RA Arnett K.L., Adams E.J., Parham P.; RT "On the sequence of A*3101."; RL Tissue Antigens 47:428-430(1996). RN [4] RP NUCLEOTIDE SEQUENCE OF 9-365 (ALLELE A*3101). RX MEDLINE=92269956; PubMed=1589035; DOI=10.1038/357329a0; RA Watkins D.I., McAdam S.N., Liu X., Stang C.R., Milford E.L., RA Levine C.G., Garber T.L., Dogon A.L., Lord C.I., Ghim S.H., RA Troup G.M., Hughes A.L., Letvin N.L.; RT "New recombinant HLA-B alleles in a tribe of South American RT Amerindians indicate rapid evolution of MHC class I loci."; RL Nature 357:329-333(1992). RN [5] RP NUCLEOTIDE SEQUENCE (ALLELE A*3104). RA Bettinotti M.P., Dhillon G., Hackett J., Simonis T.B., Marincola F.M.; RT "A new HLA-A*31 allele."; RL Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3103). RA Bunce M., Dunn P., Ross J.; RT "Characterization of two new HLA-A alleles identified by PCR-SSP."; RL Submitted (MAY-1998) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3104). RA Mitsuishi Y.; RT "New HLA-A31 allele identified in African American population."; RL Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases. RN [8] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3102). RA Dunn P.P.; RT "Characterization of an HLA-A*31 variant."; RL Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases. RN [9] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3105). RA Juji T., Akesaka T., Kashiwase K., Ishikawa Y.; RT "HLA-A31012V1."; RL Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases. RN [10] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3102). RX MEDLINE=21160440; PubMed=11260503; RX DOI=10.1034/j.1399-0039.2001.057002095.x; RA Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N., RA Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A., RA Confer D.L., Hildebrand W.H.; RT "Non-conservative substitutions distinguish previously uncharacterized RT HLA-A molecules."; RL Tissue Antigens 57:95-102(2001). RN [11] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3106). RC TISSUE=Blood; RA Anholts J.D.H.; RT "Four new HLA alleles found, and confirmation of DRB1*0322, DRB1*1433 RT and A*3106."; RL Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-31 are known: A*3101, CC A*3102, A*3103, A*3104, A*3105 (A3101v1) and A*3106. The sequence CC shown is that of A*3101. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M30578; AAA59613.1; -; Genomic_DNA. DR EMBL; M84375; AAA59599.1; -; mRNA. DR EMBL; L78918; AAB05976.1; -; Genomic_DNA. DR EMBL; AF148863; AAD39981.1; -; Genomic_DNA. DR EMBL; AF067439; AAC18859.1; -; Genomic_DNA. DR EMBL; AF067438; AAC18859.1; JOINED; Genomic_DNA. DR EMBL; AF105028; AAC79721.1; -; Genomic_DNA. DR EMBL; AF105027; AAC79721.1; JOINED; Genomic_DNA. DR EMBL; AJ239045; CAB43109.1; -; Genomic_DNA. DR EMBL; AJ239046; CAB43110.1; -; Genomic_DNA. DR EMBL; AB032597; BAA84645.1; -; Genomic_DNA. DR EMBL; AF041370; AAD02207.1; -; Genomic_DNA. DR EMBL; AF041369; AAD02207.1; JOINED; Genomic_DNA. DR EMBL; AJ506789; CAD44950.1; -; Genomic_DNA. DR EMBL; AJ506790; CAD44950.1; JOINED; Genomic_DNA. DR PIR; I72170; I72170. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P16189; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P16189; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-31 alpha chain. FT /FTId=PRO_0000018823. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 90 90 N -> K (in allele A*3102). FT /FTId=VAR_016348. FT VARIANT 114 114 A -> D (in allele A*3103). FT /FTId=VAR_016349. FT VARIANT 121 121 M -> I (in allele A*3103 and allele FT A*3104). FT /FTId=VAR_010373. FT VARIANT 138 138 Q -> R (in allele A*3103, allele A*3104 FT and allele A*3106). FT /FTId=VAR_010374. FT VARIANT 190 191 EW -> DG (in allele A*3105). FT /FTId=VAR_016350. SQ SEQUENCE 365 AA; 41004 MW; 4E760C821A3C553B CRC64; MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFTTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQER PEYWDQETRN VKAHSQIDRV DLGTLRGYYN QSEAGSHTIQ MMYGCDVGSD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL RAYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A32_HUMAN Reviewed; 365 AA. AC P10314; O77937; Q29838; Q8MHN9; Q9MYE9; Q9MYG5; Q9TQF5; Q9TQF9; DT 01-JUL-1989, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 2. DT 01-MAY-2007, entry version 68. DE HLA class I histocompatibility antigen, A-32 alpha chain precursor DE (MHC class I antigen A*32). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*3201). RA Domena J.D.; RL Submitted (DEC-1993) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE OF 25-298 (ALLELE A*3201). RX MEDLINE=87058961; PubMed=2431040; RA Wan A.M., Ennis P., Parham P., Holmes N.; RT "The primary structure of HLA-A32 suggests a region involved in RT formation of the Bw4/Bw6 epitopes."; RL J. Immunol. 137:3671-3674(1986). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*3202). RC TISSUE=Blood; RX MEDLINE=97045038; PubMed=8881042; DOI=10.1007/s002510050171; RA Zino E., Severini G.M., Mazzi B., Bordignon C., Benazzi E., RA Fleischhauer K.; RT "Sequencing of a new HLA-A*32 subtype (A*3202)."; RL Immunogenetics 45:76-77(1996). RN [4] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*3203 AND A*3204). RX MEDLINE=20309230; PubMed=10852390; RX DOI=10.1034/j.1399-0039.2000.550412.x; RA Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R., RA Ng J., Hartzman R.J., Hurley C.K.; RT "Seventeen more novel HLA-A locus alleles."; RL Tissue Antigens 55:369-373(2000). RN [5] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3203). RA Kanaan C., Hepner J., Thornton A.; RT "Confirmatory exon 2 and 3 sequence for HLA-A*3203."; RL Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE (ALLELE A*3205). RA Bettinotti M.P., Hadzikadic L., Adams S., Marincola F.M.; RT "A new HLA A-32 allele."; RL Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3206). RA Jones P.F., Hurley C.K.; RL Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-32 are known: A*3201, CC A*3202, A*3203, A*3204, A*3205 and A*3206. The sequence shown is CC that of A*3201. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; U03907; AAA03605.1; -; mRNA. DR EMBL; X97120; CAA65786.1; -; mRNA. DR EMBL; AF072762; AAC26020.1; -; Genomic_DNA. DR EMBL; AF072761; AAC26020.1; JOINED; Genomic_DNA. DR EMBL; AF137078; AAD33738.1; -; Genomic_DNA. DR EMBL; AF137077; AAD33738.1; JOINED; Genomic_DNA. DR EMBL; AF139892; AAD33849.1; -; Genomic_DNA. DR EMBL; AF139891; AAD33849.1; JOINED; Genomic_DNA. DR EMBL; AF517562; AAM78538.1; -; Genomic_DNA. DR EMBL; AF517561; AAM78538.1; JOINED; Genomic_DNA. DR EMBL; AF217560; AAF28733.1; -; mRNA. DR EMBL; AF226837; AAF29554.1; -; Genomic_DNA. DR EMBL; AF226836; AAF29554.1; JOINED; Genomic_DNA. DR PIR; A26088; HLHU32. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P10314; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P10314; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-32 alpha chain. FT /FTId=PRO_0000018824. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 89 90 RN -> GK (in allele A*3205). FT /FTId=VAR_016656. FT VARIANT 101 101 S -> N (in allele A*3203). FT /FTId=VAR_016657. FT VARIANT 121 121 M -> I (in allele A*3204). FT /FTId=VAR_016831. FT VARIANT 129 129 P -> S (in allele A*3204). FT /FTId=VAR_016832. FT VARIANT 133 133 L -> F (in allele A*3204). FT /FTId=VAR_016833. FT VARIANT 138 138 Q -> R (in allele A*3204). FT /FTId=VAR_016834. FT VARIANT 168 168 Q -> K (in allele A*3204). FT /FTId=VAR_016835. FT VARIANT 175 175 R -> H (in allele A*3202, allele A*3204 FT and allele A*3206). FT /FTId=VAR_004373. FT VARIANT 176 176 V -> E (in allele A*3204). FT /FTId=VAR_016836. FT VARIANT 180 180 L -> Q (in allele A*3202). FT /FTId=VAR_004374. FT VARIANT 185 185 E -> D (in allele A*3204). FT /FTId=VAR_016837. SQ SEQUENCE 365 AA; 41048 MW; BF7AF225329E0319 CRC64; MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAHSQTDRE SLRIALRYYN QSEAGSHTIQ MMYGCDVGPD GRLLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA MFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A33_HUMAN Reviewed; 365 AA. AC P16190; O02939; O02954; DT 01-APR-1990, integrated into UniProtKB/Swiss-Prot. DT 15-JUL-1998, sequence version 3. DT 01-MAY-2007, entry version 68. DE HLA class I histocompatibility antigen, A-33 alpha chain precursor DE (MHC class I antigen A*33) (Aw-33) (Aw-19). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*3301). RX MEDLINE=90038496; PubMed=2478623; RA Kato K., Trapani J.A., Allopenna J., Dupont B., Yang S.Y.; RT "Molecular analysis of the serologically defined HLA-Aw19 antigens. A RT genetically distinct family of HLA-A antigens comprising A29, A31, RT A32, and Aw33, but probably not A30."; RL J. Immunol. 143:3371-3378(1989). RN [2] RP SEQUENCE REVISION TO 178-179; 210 AND 345. RA Yang S.Y.; RL Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE (ALLELE A*3301). RA Szmania S., Baxter-Lowe L.A.; RL Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*3302). RX MEDLINE=93369838; PubMed=8362415; RA Kato N., Kikuchi A., Kano K., Egawa K., Takiguchi M.; RT "Molecular analysis of a novel HLA-A33 subtype associated with HLA- RT B44."; RL Tissue Antigens 41:211-213(1993). RN [5] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*3303). RX MEDLINE=95242316; PubMed=7725315; RA Balas A., Garcia-Sanchez F., Vicario J.L.; RT "Molecular characterization of a novel HLA-A33 allele (A*3303)."; RL Tissue Antigens 45:73-76(1995). RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-99 AND 122-205 (ALLELES A*3301 RP AND A*3303). RX MEDLINE=95381237; PubMed=7652743; RA Blasczyk R., Wehling J., Hahn U., Schwella N., Huhn D., Salama A.; RT "Identification of a novel HLA-A33 subtype (A*3303) and correction of RT the A*3301 sequence."; RL Tissue Antigens 45:348-352(1995). RN [7] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*3301 AND A*3303). RA Gao X., Jakobsen I., Serjeantson S.W.; RL Submitted (JAN-1995) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-33 are known: A*3301 (Aw- CC 33.1), A*3302 and A*3303. The sequence shown is that of A*3301. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M30580; AAB47870.1; -; Genomic_DNA. DR EMBL; U83416; AAB53374.1; -; mRNA. DR EMBL; L06440; AAA71914.1; -; mRNA. DR EMBL; U09740; AAA79865.1; -; mRNA. DR EMBL; X83004; CAA58125.1; -; Genomic_DNA. DR EMBL; X83005; CAA58126.1; -; Genomic_DNA. DR EMBL; X83002; CAA58123.1; -; Genomic_DNA. DR EMBL; X83003; CAA58124.1; -; Genomic_DNA. DR EMBL; U19735; AAB60652.1; -; Genomic_DNA. DR EMBL; U19736; AAB60653.1; -; Genomic_DNA. DR PIR; I38610; I38610. DR PIR; S51099; S51099. DR PIR; S51100; S51100. DR HSSP; P10315; 1HSB. DR SMR; P16190; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P16190; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-33 alpha chain. FT /FTId=PRO_0000018825. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 41 41 R -> S (in allele A*3302). FT /FTId=VAR_004375. FT VARIANT 195 195 H -> Y (in allele A*3302 and allele FT A*3303). FT /FTId=VAR_004376. FT VARIANT 217 218 AV -> PI (in allele A*3302). FT /FTId=VAR_004377. FT VARIANT 358 358 M -> V (in allele A*3302). FT /FTId=VAR_004378. FT CONFLICT 210 210 K -> R (in Ref. 3). SQ SEQUENCE 365 AA; 40892 MW; 060AE508EADEB328 CRC64; MAVMAPRTLL LLLLGALALT QTWAGSHSMR YFTTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAHSQIDRV DLGTLRGYYN QSEAGSHTIQ MMYGCDVGSD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL RAYLEGTCVE WLRRHLENGK ETLQRTDPPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A34_HUMAN Reviewed; 365 AA. AC P30453; P30454; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 61. DE HLA class I histocompatibility antigen, A-34 alpha chain precursor DE (MHC class I antigen A*34) (Aw-34) (A-10). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*3401 AND A*3402). RX MEDLINE=93056508; PubMed=1431115; RA Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J., RA Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., RA Martell R.W., du Toit E.D., Parham P.; RT "Distinctive HLA-A,B antigens of black populations formed by RT interallelic conversion."; RL J. Immunol. 149:3411-3415(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*3401 AND A*3402). RX MEDLINE=93235211; PubMed=8475492; RA Madrigal J.A., Hildebrand W.H., Belich M.P., Benjamin R.J., RA Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., RA du Toit E.D., Parham P.; RT "Structural diversity in the HLA-A10 family of alleles: correlations RT with serology."; RL Tissue Antigens 41:72-80(1993). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-34 are known: A*3401 (Aw- CC 34.1) and A*3402 (Aw-34.2). The sequence shown is that of A*3401. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X61704; CAA43873.1; -; mRNA. DR EMBL; X61705; CAA43874.1; -; mRNA. DR PIR; I37477; I37477. DR PIR; I37483; I37483. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P30453; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P30453; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-34 alpha chain. FT /FTId=PRO_0000018826. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 3 3 I -> V (in allele A*3402). FT /FTId=VAR_004379. FT VARIANT 90 90 K -> N (in allele A*3402). FT /FTId=VAR_004380. FT VARIANT 121 121 R -> I (in allele A*3402). FT /FTId=VAR_004381. FT VARIANT 129 129 P -> S (in allele A*3402). FT /FTId=VAR_004382. FT VARIANT 138 138 Q -> R (in allele A*3402). FT /FTId=VAR_004383. FT VARIANT 180 180 W -> L (in allele A*3402). FT /FTId=VAR_004384. FT VARIANT 312 312 L -> I (in allele A*3402). FT /FTId=VAR_004385. SQ SEQUENCE 365 AA; 41055 MW; 063BF63E6E6E01F6 CRC64; MAIMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDRNTRK VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG ILAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A36_HUMAN Reviewed; 365 AA. AC P30455; Q9MY89; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 60. DE HLA class I histocompatibility antigen, A-36 alpha chain precursor DE (MHC class I antigen A*36) (Aw-36). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*3601). RX MEDLINE=93056508; PubMed=1431115; RA Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J., RA Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., RA Martell R.W., du Toit E.D., Parham P.; RT "Distinctive HLA-A,B antigens of black populations formed by RT interallelic conversion."; RL J. Immunol. 149:3411-3415(1992). RN [2] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*3602). RA Rizzuto G.A., Hurley C.K.; RT "Novel HLA-A Allele."; RL Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- INTERACTION: CC P30457:HLA-A; NbExp=1; IntAct=EBI-1050524, EBI-1049899; CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-36 are known: A*3601 and CC A*3602. The sequence shown is that of A*3601. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X61700; CAA43869.1; -; mRNA. DR EMBL; AF274505; AAF78082.1; -; Genomic_DNA. DR EMBL; AF274504; AAF78082.1; JOINED; Genomic_DNA. DR PIR; I37478; I37478. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P30455; 25-298. DR IntAct; P30455; -. DR Ensembl; ENSG00000206441; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB. DR GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB. DR GO; GO:0005515; F:protein binding; IPI:IntAct. DR GO; GO:0006955; P:immune response; NAS:UniProtKB. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-36 alpha chain. FT /FTId=PRO_0000018827. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 182 182 V -> A (in allele A*3602). FT /FTId=VAR_016610. FT VARIANT 185 185 E -> D (in allele A*3602). FT /FTId=VAR_016611. SQ SEQUENCE 365 AA; 40934 MW; BA00A0085989CD3E CRC64; MAVMAPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQKME PRAPWIEQEG PEYWDQETRN MKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ IMYGCDVGPD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAVHAAEQR RVYLEGTCVE WLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEL SSQPTIPIVG IIAGLVLLGA VITGAVVAAV MWRRKSSDRK GGSYTQAASS DSAQGSDVSL TACKV // ID 1A43_HUMAN Reviewed; 365 AA. AC P30456; O19509; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 61. DE HLA class I histocompatibility antigen, A-43 alpha chain precursor DE (MHC class I antigen A*43) (Aw-43). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*4301). RX MEDLINE=93056508; PubMed=1431115; RA Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J., RA Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., RA Martell R.W., du Toit E.D., Parham P.; RT "Distinctive HLA-A,B antigens of black populations formed by RT interallelic conversion."; RL J. Immunol. 149:3411-3415(1992). RN [2] RP NUCLEOTIDE SEQUENCE (ALLELE A*4301). RX MEDLINE=93235211; PubMed=8475492; RA Madrigal J.A., Hildebrand W.H., Belich M.P., Benjamin R.J., RA Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., RA du Toit E.D., Parham P.; RT "Structural diversity in the HLA-A10 family of alleles: correlations RT with serology."; RL Tissue Antigens 41:72-80(1993). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*4301). RX MEDLINE=99446859; PubMed=10519370; RX DOI=10.1034/j.1399-0039.1999.540314.x; RA Bei M., Ng J., Slack R., Ellis J., Hartzman R.J., Hurley C.K.; RT "The relative frequencies of HLA-A*10 alleles in five major United RT States ethnic populations."; RL Tissue Antigens 54:295-299(1999). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The only allele of A-43 known is A*4301 which is CC shown here. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X61703; CAA43872.1; -; mRNA. DR EMBL; AF008306; AAB65408.1; -; Genomic_DNA. DR EMBL; AF008305; AAB65408.1; JOINED; Genomic_DNA. DR PIR; I72171; I72171. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P30456; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P30456; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-43 alpha chain. FT /FTId=PRO_0000018828. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 41033 MW; 213FC69745FB4B0B CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDLQTRN VKAHSQTDRA NLGTLRGYYN QSEDGSHTIQ RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A66_HUMAN Reviewed; 365 AA. AC P30457; P30458; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 64. DE HLA class I histocompatibility antigen, A-66 alpha chain precursor DE (MHC class I antigen A*66) (Aw-66) (A-10). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELES A*6601 AND A*6602). RX MEDLINE=92044300; PubMed=1940790; DOI=10.1084/jem.174.5.1085; RA Madrigal J., Belich M.P., Benjamin R.J., Little A.-M., RA Hildebrand W.H., Mann D.L., Parham P.; RT "Molecular definition of a polymorphic antigen (LA45) of free HLA-A RT and -B heavy chains found on the surfaces of activated B and T RT cells."; RL J. Exp. Med. 174:1085-1095(1991). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*6602). RX MEDLINE=90237739; PubMed=2139695; DOI=10.1084/jem.171.5.1431; RA Schnabl E., Stockinger H., Majdic O., Gaugitsch H., Lindley I.J.D., RA Maurer D., Hajek-Rosenmayr A., Knapp W.; RT "Activated human T lymphocytes express MHC class I heavy chains not RT associated with beta 2-microglobulin."; RL J. Exp. Med. 171:1431-1442(1990). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-322 (ALLELE A*6601). RA Hurley C., Bei M.; RL Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- INTERACTION: CC P16188:HLA-A; NbExp=1; IntAct=EBI-1049899, EBI-1044129; CC P30455:HLA-A; NbExp=1; IntAct=EBI-1049899, EBI-1050524; CC Q860B5:HLA-A; NbExp=1; IntAct=EBI-1049899, EBI-1053495; CC Q9MYE6:HLA-A; NbExp=1; IntAct=EBI-1049899, EBI-1050350; CC Q53QP2:UGCGL1; NbExp=1; IntAct=EBI-1049899, EBI-1056389; CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-66 are known: A*6601 and CC A*6602 (Aw67). The sequence shown is that of A*6601. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X61711; CAA43880.1; -; mRNA. DR EMBL; X61712; CAA43881.1; -; mRNA. DR EMBL; X51745; CAA36034.1; -; mRNA. DR EMBL; U17571; AAA56781.1; -; mRNA. DR PIR; JL0135; JL0135. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; P30457; 25-299. DR IntAct; P30457; -. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P30457; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR GO; GO:0005515; F:protein binding; IPI:IntAct. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-66 alpha chain. FT /FTId=PRO_0000018829. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 28 28 S -> W (in allele A*6602). FT /FTId=VAR_004386. FT VARIANT 114 114 D -> A (in allele A*6602). FT /FTId=VAR_004387. FT VARIANT 187 187 R -> E (in allele A*6602; requires 2 FT nucleotide substitutions). FT /FTId=VAR_004388. SQ SEQUENCE 365 AA; 41082 MW; A3272DBE4008328D CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAQSQTDRV DLGTLRGYYN QSEDGSHTIQ RMYGCDVGPD GRFLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WETAHEAEQW RAYLEGRCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VIAGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A68_HUMAN Reviewed; 365 AA. AC P01891; O19673; O19695; O19794; O19795; O43907; O77938; O98010; AC P10315; P79505; Q9MYA5; Q9MYC4; Q9TQG7; Q9TQN5; Q9UIN2; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 21-FEB-2001, sequence version 4. DT 01-MAY-2007, entry version 82. DE HLA class I histocompatibility antigen, A-68 alpha chain precursor DE (MHC class I antigen A*68) (Aw-68) (A-28). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE (ALLELE A*6802). RX MEDLINE=87252273; PubMed=3496393; RA Holmes N., Ennis P., Wan A.M., Denney D.W., Parham P.; RT "Multiple genetic mechanisms have contributed to the generation of the RT HLA-A2/A28 family of class I MHC molecules."; RL J. Immunol. 139:936-941(1987). RN [2] RP NUCLEOTIDE SEQUENCE (ALLELE A*6802). RA Domena J.D.; RL Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*6803). RX MEDLINE=97045039; PubMed=8881043; DOI=10.1007/s002510050172; RA Ellexson M., Lau M., Terasaki P., Hildebrand W.H.; RT "Molecular characterization of HLA-A*6803."; RL Immunogenetics 45:78-79(1996). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*6808). RX MEDLINE=99321037; PubMed=10395114; RX DOI=10.1034/j.1399-0039.1999.530614.x; RA Cox S.T., Arguello J.R., Marsh S.G.E., Boham E., Lau M., Kwan P.L., RA Madrigal J.A., Little A.-M.; RT "Sequence of HLA-A*6808."; RL Tissue Antigens 53:597-600(1999). RN [5] RP NUCLEOTIDE SEQUENCE (ALLELE A*68011). RC TISSUE=Blood; RA Cox S.T.; RT "Confirmation of HLA-A*68011."; RL Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE A*6817). RX MEDLINE=20340076; PubMed=10885567; RX DOI=10.1034/j.1399-0039.2000.550509.x; RA Ramon D., Scott I., Cox S.T., Pesoa S., Vullo C., Little A.M., RA Madrigal J.A.; RT "HLA-A*6817, identified in the Kolla Amerindians of north-west RT Argentina possesses a novel nucleotide substitution."; RL Tissue Antigens 55:453-454(2000). RN [7] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*6806). RA Bei M., Hurley C.K.; RL Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases. RN [8] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-206 (ALLELE A*6803). RC TISSUE=Blood; RX MEDLINE=97419180; PubMed=9271640; DOI=10.1007/s002510050304; RA Vargas-Alarcon G., Martinez-Laso J., Gomez-Casado E., Perez-Blas M., RA Granados J., Alegre R., Alvarez M., Zuniga J., Arnaiz-Villena A.; RT "Description of HLA-A*6803 and A*68N in Mazatecan Indians from RT Mexico."; RL Immunogenetics 46:446-447(1997). RN [9] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*6803). RC TISSUE=Blood; RA Blasczyk R.; RL Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases. RN [10] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELE A*6802). RA Edson S.M., Hurley C.K.; RL Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases. RN [11] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*6809 AND A*6810). RX MEDLINE=20309230; PubMed=10852390; RX DOI=10.1034/j.1399-0039.2000.550412.x; RA Ellis J., Steiner N.K., Kosman C., Henson V., Mitton W., Koester R., RA Ng J., Hartzman R.J., Hurley C.K.; RT "Seventeen more novel HLA-A locus alleles."; RL Tissue Antigens 55:369-373(2000). RN [12] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 3-206 (ALLELE A*6816). RX MEDLINE=20260982; PubMed=10803837; DOI=10.1007/s002510050618; RA Gomez-Casado E., Martinez-Laso J., Gonzalez-Hevilla M., Longas J., RA Rubio I., Silvera-Redondo C., Garcia-Gomez A., Lowy E., RA Arnaiz-Villena A.; RT "A novel HLA-A*6816 allele possible generated by a point mutation in a RT Chilean from Punta Arenas (Magellan Strait)."; RL Immunogenetics 51:257-260(2000). RN [13] RP NUCLEOTIDE SEQUENCE OF 26-206 (ALLELES A*6807 AND A*6817). RX MEDLINE=21160440; PubMed=11260503; RX DOI=10.1034/j.1399-0039.2001.057002095.x; RA Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N., RA Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A., RA Confer D.L., Hildebrand W.H.; RT "Non-conservative substitutions distinguish previously uncharacterized RT HLA-A molecules."; RL Tissue Antigens 57:95-102(2001). RN [14] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 26-297 (ALLELE A*6801). RX MEDLINE=86055720; PubMed=3877632; RA Holmes N., Parham P.; RT "Exon shuffling in vivo can generate novel HLA class I molecules."; RL EMBO J. 4:2849-2854(1985). RN [15] RP PARTIAL PROTEIN SEQUENCE OF 25-294 (A*6801). RX MEDLINE=82247941; PubMed=6179086; RA Lopez de Castro J.A., Strominger J.L., Strong D.M., Orr H.T.; RT "Structure of crossreactive human histocompatibility antigens HLA-A28 RT and HLA-A2: possible implications for the generation of HLA RT polymorphism."; RL Proc. Natl. Acad. Sci. U.S.A. 79:3813-3817(1982). RN [16] RP X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (A*6801). RX MEDLINE=93078854; PubMed=1448153; DOI=10.1038/360364a0; RA Guo H.-C., Jardetzky T.S., Garrett T.P.J., Lane W.S., Strominger J.L., RA Wiley D.C.; RT "Different length peptides bind to HLA-Aw68 similarly at their ends RT but bulge out in the middle."; RL Nature 360:364-366(1992). RN [17] RP X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 25-294 (A*6801). RX MEDLINE=93078855; PubMed=1448154; DOI=10.1038/360367a0; RA Silver M.L., Guo H.-C., Strominger J.L., Wiley D.C.; RT "Atomic structure of a human MHC molecule presenting an influenza RT virus peptide."; RL Nature 360:367-369(1992). RN [18] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 25-199 (A*6801). RX MEDLINE=95166800; PubMed=7862664; RA Collins E.J., Garboczi D.N., Karpusas M.N., Wiley D.C.; RT "The three-dimensional structure of a class I major histocompatibility RT complex molecule missing the alpha 3 domain of the heavy chain."; RL Proc. Natl. Acad. Sci. U.S.A. 92:1218-1221(1995). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-68 are known: A*6801 CC (Aw68.1), A*6802, A*6803. A*6804, A*6805, A*6806, A*6807, A*6808, CC A*6809, A*6810, A*6816 and A*6817. The sequence shown is that of CC A*6801. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; U03861; AAA03602.1; -; Unassigned_DNA. DR EMBL; X03070; CAB56605.1; -; Genomic_DNA. DR EMBL; X03071; CAB56606.1; -; Genomic_DNA. DR EMBL; U41057; AAB41292.1; -; mRNA. DR EMBL; AJ315642; CAC44382.1; -; Genomic_DNA. DR EMBL; AF144013; AAF74211.1; -; Genomic_DNA. DR EMBL; AJ245567; CAB59722.1; -; Genomic_DNA. DR EMBL; U91628; AAB50567.1; -; Genomic_DNA. DR EMBL; U91627; AAB50567.1; JOINED; Genomic_DNA. DR EMBL; U89946; AAB82079.1; -; Genomic_DNA. DR EMBL; U89947; AAB82080.1; -; Genomic_DNA. DR EMBL; AJ001274; CAA04647.1; -; mRNA. DR EMBL; AF072770; AAC25782.1; -; Genomic_DNA. DR EMBL; AF072769; AAC25782.1; JOINED; Genomic_DNA. DR EMBL; AF135545; AAD22270.1; -; Genomic_DNA. DR EMBL; AF135544; AAD22270.1; JOINED; Genomic_DNA. DR EMBL; AF108431; AAD27539.1; -; Genomic_DNA. DR EMBL; AF108430; AAD27539.1; JOINED; Genomic_DNA. DR EMBL; AJ223972; CAA11708.1; -; Genomic_DNA. DR EMBL; AF041372; AAD02208.1; -; Genomic_DNA. DR EMBL; AF041371; AAD02208.1; JOINED; Genomic_DNA. DR EMBL; AF268398; AAF73477.1; -; Genomic_DNA. DR EMBL; AF268397; AAF73477.1; JOINED; Genomic_DNA. DR UniGene; Hs.181244; -. DR PDB; 1HSB; X-ray; A=25-294. DR PDB; 1TMC; X-ray; A=25-199. DR PDB; 2HLA; X-ray; A=25-294. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR LinkHub; P01891; -. DR ArrayExpress; P01891; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW 3D-structure; Direct protein sequencing; Glycoprotein; KW Host-virus interaction; Immune response; Membrane; MHC I; KW Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-68 alpha chain. FT /FTId=PRO_0000018830. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...). FT DISULFID 125 188 FT DISULFID 227 283 FT VARIANT 36 36 V -> M (in allele A*6802). FT /FTId=VAR_004389. FT VARIANT 86 87 RN -> EE (in allele A*6810). FT /FTId=VAR_010362. FT VARIANT 94 94 Q -> H (in allele A*6803, allele A*6804 FT and allele A*6805). FT /FTId=VAR_010363. FT VARIANT 97 97 T -> I (in allele A*6804). FT /FTId=VAR_010364. FT VARIANT 98 98 D -> H (in allele A*6805). FT /FTId=VAR_010365. FT VARIANT 121 121 M -> R (in allele A*6802). FT /FTId=VAR_004390. FT VARIANT 129 129 S -> P (in allele A*6802). FT /FTId=VAR_004391. FT VARIANT 138 138 R -> E (in allele A*6806; requires 2 FT nucleotide substitutions). FT /FTId=VAR_010366. FT VARIANT 138 138 R -> H (in allele A*6802). FT /FTId=VAR_004392. FT VARIANT 140 140 D -> H (in allele A*6806 and allele FT A*6807). FT /FTId=VAR_010367. FT VARIANT 140 140 D -> V (in allele A*6817). FT /FTId=VAR_010368. FT VARIANT 140 140 D -> Y (in allele A*6802). FT /FTId=VAR_004393. FT VARIANT 175 175 H -> L (in allele A*6816). FT /FTId=VAR_010369. FT VARIANT 180 180 W -> L (in allele A*6808). FT /FTId=VAR_010370. FT VARIANT 180 180 W -> Q (in allele A*6809; requires 2 FT nucleotide substitutions). FT /FTId=VAR_010371. FT CONFLICT 206 206 T -> A (in Ref. 12). FT CONFLICT 231 231 S -> G (in Ref. 15). FT STRAND 27 36 FT STRAND 41 43 FT STRAND 45 52 FT STRAND 55 61 FT STRAND 64 66 FT HELIX 74 76 FT HELIX 81 108 FT STRAND 118 127 FT STRAND 133 142 FT STRAND 145 150 FT STRAND 157 161 FT HELIX 162 173 FT HELIX 176 185 FT HELIX 187 198 FT HELIX 200 203 FT STRAND 210 235 FT STRAND 238 243 FT STRAND 246 248 FT STRAND 252 254 FT STRAND 261 263 FT STRAND 265 274 FT HELIX 278 280 FT STRAND 281 286 FT STRAND 290 292 SQ SEQUENCE 365 AA; 40909 MW; 78539C59DB8B1DFC CRC64; MAVMAPRTLV LLLSGALALT QTWAGSHSMR YFYTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDRNTRN VKAQSQTDRV DLGTLRGYYN QSEAGSHTIQ MMYGCDVGSD GRFLRGYRQD AYDGKDYIAL KEDLRSWTAA DMAAQTTKHK WEAAHVAEQW RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWVA VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA VITGAVVAAV MWRRKSSDRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1A74_HUMAN Reviewed; 365 AA. AC P30459; O19647; O43906; O46874; Q95IZ5; Q9UIN1; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 62. DE HLA class I histocompatibility antigen, A-74 alpha chain precursor DE (MHC class I antigen A*74) (Aw-74) (Aw-19). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*7401). RX MEDLINE=93056508; PubMed=1431115; RA Madrigal J.A., Belich M.P., Hildebrand W.H., Benjamin R.J., RA Little A.-M., Zemmour J., Ennis P.D., Ward F.E., Petzl-Erler M.L., RA Martell R.W., du Toit E.D., Parham P.; RT "Distinctive HLA-A,B antigens of black populations formed by RT interallelic conversion."; RL J. Immunol. 149:3411-3415(1992). RN [2] RP NUCLEOTIDE SEQUENCE (ALLELE A*7401). RA Hurley C.; RL Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-206 (ALLELES A*7402 AND A*7403). RC TISSUE=Blood; RX MEDLINE=97051454; PubMed=8896180; RA Blasczyk R., Wehling J., Onaldi-Mohr D., Rebmann V., RA Chandanayingyong D., Grosse-Wilde H.; RT "Structural definition of the A*74 group: implications for matching in RT bone marrow transplantation with alternative donors."; RL Tissue Antigens 48:205-209(1996). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 25-206 (ALLELE A*7404). RX MEDLINE=21108617; PubMed=11169261; RX DOI=10.1034/j.1399-0039.2001.057001070.x; RA Cox S.T., Mcwhinnie A.J., Koester R.P., Heine U., Holman R., RA Madrigal A.J., Little A.-M.; RT "Further diversity at HLA-A and -B loci identified in Afro-Caribbean RT potential bone marrow donors."; RL Tissue Antigens 57:70-72(2001). RN [5] RP NUCLEOTIDE SEQUENCE OF 25-206 (ALLELE A*7405). RX MEDLINE=21160440; PubMed=11260503; RX DOI=10.1034/j.1399-0039.2001.057002095.x; RA Hickman H.D., Cavett J.W., Ellexson-Turner M.E., Sparkman J.N., RA Bennett T.T., Turner S., Sidebottom D.A., Trachtenberg E.A., RA Confer D.L., Hildebrand W.H.; RT "Non-conservative substitutions distinguish previously uncharacterized RT HLA-A molecules."; RL Tissue Antigens 57:95-102(2001). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The following alleles of A-74 are known: A*7401 CC A*7402, A*7403, A*7404 and A*7405. The sequence shown is that of CC A*7401. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X61701; CAA43870.1; -; mRNA. DR EMBL; U17569; AAA56779.1; -; mRNA. DR EMBL; U17570; AAA56780.1; -; mRNA. DR EMBL; AJ223060; CAA11063.1; -; mRNA. DR EMBL; AJ002678; CAA05681.1; -; mRNA. DR EMBL; AJ249370; CAB58124.1; -; Genomic_DNA. DR EMBL; AF255721; AAK49188.1; -; Genomic_DNA. DR EMBL; AF255720; AAK49188.1; JOINED; Genomic_DNA. DR PIR; I37482; I37482. DR HSSP; P10315; 1HSB. DR SMR; P30459; 25-299. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; P30459; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Polymorphism; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-74 alpha chain. FT /FTId=PRO_0000018831. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. FT VARIANT 23 23 R -> W (in allele A*7402). FT /FTId=VAR_010375. FT VARIANT 86 86 Q -> G (in allele A*7404; requires 2 FT nucleotide substitutions). FT /FTId=VAR_016612. FT VARIANT 90 90 N -> K (in allele A*7404). FT /FTId=VAR_016613. FT VARIANT 97 97 T -> A (in allele A*7405). FT /FTId=VAR_016614. FT VARIANT 103 103 G -> A (in allele A*7403). FT /FTId=VAR_016615. SQ SEQUENCE 365 AA; 40891 MW; C94BF2569A852371 CRC64; MAVMAPRTLL LLLLGALALT QTRAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDTQFVRF DSDAASQRME PRAPWIEQEG PEYWDQETRN VKAHSQTDRV DLGTLRGYYN QSEAGSHTIQ MMYGCDVGPD GRLLRGYQQD AYDGKDYIAL NEDLRSWTAA DMAAQITQRK WEAARVAEQL RAYLEGTCVE WLRRYLENGK ETLQRTDAPK THMTHHAVSD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAS VVVPSGQEQR YTCHVQHEGL PKPLTLRWEP SSQPTIPIVG IIAGLVLFGA MFAGAVVAAV RWRRKSSDRK GGSYSQAASS DSAQGSDMSL TACKV // ID 1A80_HUMAN Reviewed; 365 AA. AC Q09160; DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 1. DT 01-MAY-2007, entry version 58. DE HLA class I histocompatibility antigen, A-80 alpha chain precursor DE (MHC class I antigen A*80) (Aw-80) (A-1). GN Name=HLA-A; Synonyms=HLAA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*8001). RX MEDLINE=94245293; PubMed=8188325; DOI=10.1007/BF00176169; RA Balas A., Garcia-Sanchez F., Gomez-Reino F., Vicario J.L.; RT "Characterization of a new and highly distinguishable HLA-A allele in RT a Spanish family."; RL Immunogenetics 39:452-452(1994). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ALLELE A*8001). RX PubMed=8284791; RA Domena J.D., Hildebrand W.H., Bias W.B., Parham P.; RT "A sixth family of HLA-A alleles defined by HLA-A*8001."; RL Tissue Antigens 42:156-159(1993). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). Interacts with human herpesvirus 8 MIR1 protein CC (By similarity). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- PTM: Polyubiquitinated in a post ER compartment by interaction CC with human herpesvirus 8 MIR1 protein. This targets the protein CC for rapid degradation via the ubiquitin system (By similarity). CC -!- POLYMORPHISM: The only allele of A-80 known is A*8001 which is CC shown here. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; U03754; AAC04322.1; -; mRNA. DR EMBL; L18898; AAA17012.1; -; mRNA. DR PIR; I59638; I38439. DR UniGene; Hs.181244; -. DR HSSP; P10315; 1HSB. DR SMR; Q09160; 25-298. DR Ensembl; ENSG00000204632; Homo sapiens. DR HGNC; HGNC:4931; HLA-A. DR MIM; 142800; gene. DR ArrayExpress; Q09160; -. DR GermOnline; ENSG00000204632; Homo sapiens. DR GO; GO:0005887; C:integral to plasma membrane; NAS:UniProtKB. DR GO; GO:0032393; F:MHC class I receptor activity; NAS:UniProtKB. DR GO; GO:0006955; P:immune response; NAS:UniProtKB. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Host-virus interaction; Immune response; Membrane; KW MHC I; Signal; Transmembrane; Ubl conjugation. FT SIGNAL 1 24 FT CHAIN 25 365 HLA class I histocompatibility antigen, FT A-80 alpha chain. FT /FTId=PRO_0000018832. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 297 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40792 MW; CE1BC1CD60CA8FA8 CRC64; MAVMPPRTLL LLLSGALALT QTWAGSHSMR YFFTSVSRPG RGEPRFIAVG YVDDSQFVQF DSDAASQRME PRAPWIEQEE PEYWDEETRN VKAHSQTNRA NLGTLRGYYN QSEDGSHTIQ IMYGCDVGSD GRFLRGYRQD AYDGKDYIAL NEDLRSWTAA DMAAQITKRK WEAARRAEQL RAYLEGECVD GLRRYLENGK ETLQRTDPPK THMTHHPISD HEATLRCWAL SFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGKEKR YTCHVQHEGL PEPLTLRWEP SSQPTIPIVG IIAGLVLLGA VIAGAVVAAV MWRKKSSVRK GGSYSQAASS DSAQGSDVSL TACKV // ID 1B01_GORGO Reviewed; 362 AA. AC P30379; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 45. DE Class I histocompatibility antigen, GOGO-B0101 alpha chain precursor. OS Gorilla gorilla gorilla (Lowland gorilla). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Gorilla. OX NCBI_TaxID=9595; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=92078860; PubMed=1744581; DOI=10.1084/jem.174.6.1491; RA Lawlor D.A., Warren E., Taylor P., Parham P.; RT "Gorilla class I major histocompatibility complex alleles: comparison RT to human and chimpanzee class I."; RL J. Exp. Med. 174:1491-1509(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X60255; CAA42807.1; -; mRNA. DR PIR; JH0539; JH0539. DR HSSP; Q29961; 1HSA. DR SMR; P30379; 25-300. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 362 Class I histocompatibility antigen, GOGO- FT B0101 alpha chain. FT /FTId=PRO_0000018901. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 362 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 362 AA; 40171 MW; 419EEE29817165A4 CRC64; MRVTAPRTLL LLLSAALALT ETWAGSHSMR YFDTAVSRPG RGEPRFITVG YVDDTQFVRF DSDAASPRME PRAPWIEQEG PEYWDRETQT SKAQAQTDRE NLRIALRYYN QSEAGSHTIQ RMFGCDVGPD GRLLRGYSQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL RAYLEGTCVE WLRRYLENGR ETLQRADTPK THVTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEER YTCHVQHEGL PKPLTLRWEP SSQSTIPIVG IVAGLAVLAV VVIGAVVTAV ICRRKSSGGK GGSYSQAASS DSAQGSDVSL TA // ID 1B01_PANTR Reviewed; 359 AA. AC P13750; DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1990, sequence version 1. DT 01-MAY-2007, entry version 52. DE CHLA class I histocompatibility antigen, B-1 alpha chain precursor DE (Fragment). OS Pan troglodytes (Chimpanzee). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pan. OX NCBI_TaxID=9598; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=89030641; PubMed=2460344; RA Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.; RT "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for RT trans-species mode of evolution."; RL EMBO J. 7:2765-2774(1988). RN [2] RP SEQUENCE REVISION. RA Mayer W.; RL Submitted (FEB-1989) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X13115; CAA31507.1; -; mRNA. DR HSSP; Q29961; 1HSA. DR SMR; P13750; 21-294. DR KEGG; ptr:450150; -. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL <1 20 By similarity. FT CHAIN 21 359 CHLA class I histocompatibility antigen, FT B-1 alpha chain. FT /FTId=PRO_0000018916. FT TOPO_DOM 21 305 Extracellular (Potential). FT TRANSMEM 306 329 Potential. FT TOPO_DOM 330 359 Cytoplasmic (Potential). FT DOMAIN 205 291 Ig-like C1-type. FT REGION 21 110 Alpha-1. FT REGION 111 202 Alpha-2. FT REGION 203 294 Alpha-3. FT REGION 295 305 Connecting peptide. FT CARBOHYD 106 106 N-linked (GlcNAc...) (By similarity). FT DISULFID 121 184 By similarity. FT DISULFID 223 279 By similarity. FT NON_TER 1 1 SQ SEQUENCE 359 AA; 40174 MW; 858ACBAF74D6829D CRC64; APRTVLLLLS AALALTETWA GSHSMRYFYT SVSRPGRGEP RFITVGYVDD TQFVRFDSDA ASPRMEPRAP WIEQEGPEYW DRETRNMKAS AQTDRENLRI ALRYYNQSEA GSHTWQTMYG CDMGPDGRLL RGYGQYAYDG KDYIALNEDL SSWTAADTAA QITQRKWEAA REAEQRRAYL EGTCVEWLRR YLENGKETLQ RADPPKTHVT HHPISDHEAT LRCWALGFYP AEITLTWQRD GEDQTQDTEL VETRPEGDRT FQKWAAVVVP SGEEQRYTCH VQHEGLPKPL TLRWEPSSQS TIPIVGIVAG LAVLVVTVAV VAVVAAVMCR RKSSGGKGGS YSQAASSDSA QGSDVSLTA // ID 1B01_SAGOE Reviewed; 365 AA. AC P30516; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 47. DE Class I histocompatibility antigen, B alpha chain precursor. OS Saguinus oedipus (Cotton-top tamarin). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Platyrrhini; Cebidae; Callitrichinae; Saguinus. OX NCBI_TaxID=9490; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=90111120; PubMed=2104912; RA Watkins D.I., Letvin N.L., Hughes A.L., Tedder T.F.; RT "Molecular cloning of cDNA that encode MHC class I molecules from a RT New World primate (Saguinus oedipus). Natural selection acts at RT positions that may affect peptide presentation to T cells."; RL J. Immunol. 144:1136-1143(1990). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; M33476; AAA36952.1; ALT_INIT; mRNA. DR PIR; I72217; I72217. DR HSSP; P30504; 1IM9. DR SMR; P30516; 25-298. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 365 Class I histocompatibility antigen, B FT alpha chain. FT /FTId=PRO_0000018921. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 365 Cytoplasmic (Potential). FT DOMAIN 209 297 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 365 AA; 40999 MW; B79A9E1FE54C5634 CRC64; MTVMAPRTLL LLLSGALVLT ETWAGSHSMR YFSTAVSRPG REEPRYIEVG YVDDTQFVRF DSDAASPRME PRAQWVEKEG REYWEEETQR AKAFAQTFRV NLQTALGYYN QSEAGSHTIQ MMSGCDLGPD GRLLRGYDQH AYDGKDYISL NEDLRSWTAA DVAAQITQRK WEAANEAERT RAYLEGTCVE WLHRYLENGK ETLQRAEPPK THVTHHPVSD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DMELVETRPT GNGTFQKWAA VVVLSGEEHR YTCHVQHEGL PEPLTLRWEP PSQPTIPIMG IVAILAILGA VVTGAVVTAV MWRKKSSDKK GGSYSQAARS DSAQGSDVSL TACKV // ID 1B02_GORGO Reviewed; 362 AA. AC P30380; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 45. DE Class I histocompatibility antigen, GOGO-B0102 alpha chain precursor. OS Gorilla gorilla gorilla (Lowland gorilla). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Gorilla. OX NCBI_TaxID=9595; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=92078860; PubMed=1744581; DOI=10.1084/jem.174.6.1491; RA Lawlor D.A., Warren E., Taylor P., Parham P.; RT "Gorilla class I major histocompatibility complex alleles: comparison RT to human and chimpanzee class I."; RL J. Exp. Med. 174:1491-1509(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X60693; CAA43101.1; -; mRNA. DR PIR; JH0540; JH0540. DR HSSP; Q29961; 1HSA. DR SMR; P30380; 25-300. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 362 Class I histocompatibility antigen, GOGO- FT B0102 alpha chain. FT /FTId=PRO_0000018902. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 362 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 362 AA; 40205 MW; E19EEE2B7CC7BECD CRC64; MRVTAPRTLL LLLSAALALT ETWAGSHSMR YFDTAVSRPG RGEPRFITVG YVDDTQFVRF DSDAASPRME PRAPWIEQEG PEYWDRETQT SKAQAQTDRE NLRIALRYYN QSEAGSHTFQ RMFGCDVGPD GRLLRGYSQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL RAYLEGTCVE WLRRYLENGR ETLQRADTPK THVTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEER YTCHVQHEGL PKPLTLRWEP SSQSTIPIVG IVAGLAVLAV VVIGAVVTAV ICRRKSSGGK GGSYSQAASS DSAQGSDVSL TA // ID 1B02_PANTR Reviewed; 362 AA. AC P13751; Q9MXK0; DT 01-JAN-1990, integrated into UniProtKB/Swiss-Prot. DT 01-JAN-1990, sequence version 1. DT 01-MAY-2007, entry version 53. DE CHLA class I histocompatibility antigen, B-2 alpha chain precursor. OS Pan troglodytes (Chimpanzee). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Pan. OX NCBI_TaxID=9598; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=89030641; PubMed=2460344; RA Mayer W.E., Jonker M., Klein D., Ivanyi P., van Seventer G., Klein J.; RT "Nucleotide sequences of chimpanzee MHC class I alleles: evidence for RT trans-species mode of evolution."; RL EMBO J. 7:2765-2774(1988). RN [2] RP SEQUENCE REVISION. RA Mayer W.; RL Submitted (FEB-1989) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Blood; RX MEDLINE=20322475; PubMed=10866106; DOI=10.1007/s002510050638; RA de Groot N.G., Otting N., Arguello R., Watkins D.I., Doxiadis G.G., RA Madrigal J.A., Bontrop R.E.; RT "Major histocompatibility complex class I diversity in a West African RT chimpanzee population: implications for HIV research."; RL Immunogenetics 51:398-409(2000). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X13116; CAA31508.1; -; mRNA. DR EMBL; AF168411; AAF72792.2; -; mRNA. DR PIR; S03538; S03538. DR HSSP; P30474; 1A9E. DR SMR; P13751; 25-300. DR KEGG; ptr:450202; -. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 362 CHLA class I histocompatibility antigen, FT B-2 alpha chain. FT /FTId=PRO_0000018917. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 362 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 362 AA; 40488 MW; FFDB2991044DAA83 CRC64; MQVTAPRTVL LLLSAALALT ETWAGSHSMK YFYTAVSRPG RGEPRFISVG YVDDTQFVWF DSDAASPREE PRAPWIEQEG PEYWDRETQI SKTNAQTYRE SLRNLRGYYN QSEAGSHIIQ RMYGCDMGPD GRLLRGYEQY AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAARWAEQL RAYLEGTCVE WLRRYLENGK ETLQRADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP SSQSTIPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAASS DSAQGSDVSL TA // ID 1B03_GORGO Reviewed; 362 AA. AC P30381; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 45. DE Class I histocompatibility antigen, GOGO-B0103 alpha chain precursor. OS Gorilla gorilla gorilla (Lowland gorilla). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Gorilla. OX NCBI_TaxID=9595; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=92078860; PubMed=1744581; DOI=10.1084/jem.174.6.1491; RA Lawlor D.A., Warren E., Taylor P., Parham P.; RT "Gorilla class I major histocompatibility complex alleles: comparison RT to human and chimpanzee class I."; RL J. Exp. Med. 174:1491-1509(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X60254; CAA42806.1; -; mRNA. DR PIR; JH0541; JH0541. DR HSSP; Q29961; 1HSA. DR SMR; P30381; 25-300. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; MHC_I_alpha_C. DR Gene3D; G3DSA:3.30.500.10; G3DSA:3.30.500.10; 1. DR Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 1. DR Pfam; PF07654; C1-set; 1. DR Pfam; PF00129; MHC_I; 1. DR Pfam; PF06623; MHC_I_C; 1. DR PRINTS; PR01638; MHCCLASSI. DR ProDom; PD000050; MHC_I; 1. DR SMART; SM00407; IGc1; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00290; IG_MHC; 1. KW Glycoprotein; Immune response; Membrane; MHC I; Signal; Transmembrane. FT SIGNAL 1 24 By similarity. FT CHAIN 25 362 Class I histocompatibility antigen, GOGO- FT B0103 alpha chain. FT /FTId=PRO_0000018903. FT TOPO_DOM 25 308 Extracellular (Potential). FT TRANSMEM 309 332 Potential. FT TOPO_DOM 333 362 Cytoplasmic (Potential). FT DOMAIN 209 295 Ig-like C1-type. FT REGION 25 114 Alpha-1. FT REGION 115 206 Alpha-2. FT REGION 207 298 Alpha-3. FT REGION 299 308 Connecting peptide. FT CARBOHYD 110 110 N-linked (GlcNAc...) (By similarity). FT DISULFID 125 188 By similarity. FT DISULFID 227 283 By similarity. SQ SEQUENCE 362 AA; 40249 MW; 3DEE82572BD81469 CRC64; MRVTAPRTLL LLLSAALALT ETWAGSHSMR YFDTAVSRPG RGEPRFITVG YVDDTQFVRF DSDAASPRME PRAPWIEQEG PEYWDRETQT SKAQAQTDRE NLRIALRYYN QSEAGSHTIQ WMYGCDMGPD GRLLRGYSQS AYDGKDYIAL NEDLSSWTAA DTAAQITQRK WEAAREAEQL RAYLEGTCVE WLRRYLENGR ETLQRADTPK THVTHHPISD HEATLRCWAL GFYPAEITLT WQRDGEDQTQ DTELVETRPA GDGTFQKWAA VVVPSGEEER YTCHVQHEGL PKPLTLRWEP SSQSTIPIVG IVAGLAVLAV VVIGAVVTAV ICRRKSSGGK GGSYSQAASS DSAQGSDVSL TA // ID 1B04_GORGO Reviewed; 363 AA. AC P30382; DT 01-APR-1993, integrated into UniProtKB/Swiss-Prot. DT 01-APR-1993, sequence version 1. DT 01-MAY-2007, entry version 47. DE Class I histocompatibility antigen, GOGO-B0201 alpha chain precursor. OS Gorilla gorilla gorilla (Lowland gorilla). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Gorilla. OX NCBI_TaxID=9595; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=92078860; PubMed=1744581; DOI=10.1084/jem.174.6.1491; RA Lawlor D.A., Warren E., Taylor P., Parham P.; RT "Gorilla class I major histocompatibility complex alleles: comparison RT to human and chimpanzee class I."; RL J. Exp. Med. 174:1491-1509(1991). CC -!- FUNCTION: Involved in the presentation of foreign antigens to the CC immune system. CC -!- SUBUNIT: Heterodimer of an alpha chain and a beta chain (beta-2- CC microglobulin). CC -!- SUBCELLULAR LOCATION: Membrane; single-pass type I membrane CC protein. CC -!- SIMILARITY: Belongs to the MHC class I family. CC -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like) CC domain. DR EMBL; X60253; CAA42805.1; -; mRNA. DR PIR; JH0542; JH0542. DR HSSP; P30474; 1A9E. DR SMR; P30382; 25-300. DR InterPro; IPR007110; Ig-like. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003597; Ig_C1-set. DR InterPro; IPR003006; Ig_MHC. DR InterPro; IPR001039; MHC_I_alpha_A1A2. DR InterPro; IPR010579; M